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Abstract
Acute gram-negative bacterial infections are a leading cause of mortality among the
nosocomial infections. Increasing numbers of immunosuppressed individuals and growing
numbers of antibiotic resistant strains make antibiotic treatment difficult. Neutrophils are the
first cells recruited to the site of infection and are critical players in the host defense against
gram-negative bacterial pneumonia. Therefore, identification of targets that boost neutrophilassociated host defense in the lung is essential in designing better therapies to control
pulmonary infections. Production of chemokines is an important step for neutrophil
recruitment. Monocyte chemoattractant protein-1 (MCP-1) is a chemokine that is important
for monocyte and T-lymphocyte influx. It is important for the host defense during Listeria
monocytogenes and Streptococcus pneumoniae infection. However, the role of MCP-1 during
pulmonary gram-negative infections is not known. We hypothesized that MCP-1 is essential
for the host defense during a gram-negative infection. To test the hypothesis, we infected
MCP-1 gene-deficient (MCP-1-/-) mice and controls intratracheally (i.t.) with E. coli (106
CFUs/mouse) and Klebsiella pneumoniae (103 CFUs/mouse). We found that MCP-1 is
critical for host defense against gram-negative infections, mainly by recruiting neutrophils to
the site of infection. MCP-1 utilizes it’s receptor, CCR2, to recruit neutrophils directly and
indirectly by regulating the expression of cytokines (IL-6, TNF-) and chemokines (KC,
MIP-2) through activation of NF-B and MAPKs. We also observed that MCP-1 can regulate
expression of G-CSF and thereby neutrophil numbers in circulation during Kp infection. In
addition, exogenous administration of rG-CSF can restore the defects in host defense in
MCP-1-/- mice following gram-negative Kp infection. This study demonstrates an
unrecognized role of MCP-1 in host defense during gram negative bacterial pneumonia.
These findings bolster pleiotropic effects of MCP-1 in the host defense and demonstrate a

xii

potential role as a therapeutic agent to augment host defense during acute bacterial
pneumonia.
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Chapter 1
Introduction
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Acute lower respiratory tract infections (ALRTI) are major causes of mortality throughout the
world[1]. Unlike other infectious diseases that are common in poor communities, ALRTI
cause significant morbidity and mortality across the socio-economic spectrum[2]. Although
ALRTI can be caused by several infectious agents, bacterial infections claim thousands of
lives every year[1, 3]. Medical and public health advances have been made in treating lung
infections, yet there has been little or no improvement in death rates in the US and
worldwide. The current treatment strategy for bacterial pneumonia is antibiotics. Wide spread
antibiotic use has resulted in the emergence of multi-drug resistant bacterial strains [4, 5].
Moreover, growing populations of immunocompromised individuals make the treatment of
bacterial pneumonia complicated. Therefore, novel approaches to treat bacterial pneumonia
are warranted. Immunotherapy to modulate the immune response is an important therapeutic
strategy [6, 7].
Pulmonary immune response against pathogens involves both innate and adaptive responses.
Innate immune response is non-specific and occurs very quickly upon exposure to a
pathogen. In contrast, the adaptive response is pathogen-specific, takes several days to
develop and has a memory response. During acute infections, innate host defense plays a vital
role in eliminating the pathogen [8, 9]. Neutrophils are the first cells recruited to the site to
contain the infection. Neutrophil recruitment is a critical event during anti-bacterial host
defense and involves a coordinated signal network that involves cytokines, chemokines,
cellular adhesion molecules, leukocytes, epithelial cells and endothelial cells. In this regard,
chemokines play a critical role [10, 11]. Monocyte chemoattractant protein 1 (MCP-1) is a
member of the chemokine [C-C motif] family and a potent monocyte and T cell
chemoattractant[12, 13]. MCP-1 has been very well studied for its role in monocyte
recruitment. MCP-1 is produced by a variety of cells including epithelial cells [14],
endothelial cells, fibroblasts [15] and monocytes/macrophages [16]. MCP-1 interacts with its
2

G-protein–coupled transmembrane receptor CCR-2 to bring about the biological effects [17,
18]. This chemokine is implicated in various acute and chronic disease conditions, including
acute respiratory distress syndrome (ARDS) [19, 20]. Studies have shown that MCP-1 is
important for the host defense during Streptococcus pneumoniae[21], Pseudomonas
aeruginosa [22] and Cryptococcus neoformans [13] infections in different models. MCP-1
has been shown to promote bacterial killing by macrophages during S. pneumoniae, P.
aeruginosa and S. typhimurium infections alternatively it is important for the clearance of
apoptotic cells and therefore helps in resolution and repair during P. aeruginosa infection of
the lung [22]. Growing evidence suggests that MCP-1 can play a significant role in neutrophil
chemotaxis [19, 23]. However, the role of MCP-1 in neutrophil recruitment during acute
gram negative bacterial infection of the lung has not been studied.
We hypothesized that MCP-1 is important for neutrophil recruitment and host defense during
gram-negative bacterial pneumonia. As MCP-1 has a pleiotropic role in immune
mechanisms, it is a potential therapeutic target by boosting immune defense against bacterial
infections. However, a more comprehensive understanding of the role of MCP-1 in the host
defense is needed. Therefore, the major goals of this dissertation are to 1) determine the role
of MCP-1 in neutrophil mediated host defense during gram-negative pneumonia and 2)
determine the mechanism behind neutrophil recruitment following gram-negative bacterial
infection. These goals were achieved by using MCP-1 gene deficient mice and their controls
(C57BL6) and infecting them intratracheally (i.t.) either with E. coli (1X106 CFUs/animal) or
Klebsiella pneumoniae (1X103 CFUs/animal).
The specific objectives of the first research goal were A) to use enzyme linked
immunosorbent assay (ELISA) to determine the kinetics of MCP-1 in the bronchoalveolar
lavage fluid (BALF) during gram-negative bacterial pneumonia; B) to use bone marrow
transplantation to identify the cellular source of MCP-1 during infection; C) to assess
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neutrophil numbers in BALF and in lung with a hemocytometer and myeloperoxidase assay
and D) to characterize the expression of pro-inflammatory mediators (cytokine, chemokines,
cellular adhesion molecules, NF-B and MAPKs) in lungs of mice after i.t. infection with
bacteria. Expression of cytokines and chemokines were measured by ELISA and expression
and activation of NF-B and MAPKs will be determined by immunoblot analysis.
The specific objectives of the second research goal were A) to determine the expression level
of CCR2 after infection with gram-negative bacterial pneumonia; by flow cytometry and
labelled antibody against the CCR2 receptor; B) to determine whether neutrophils can move
by chemotaxis towards recombinant MCP-1 (rMCP-1) in-vitro as measured by the neutrophil
transmigration assay using a Transwell system and bone marrow neutrophils after gramnegative bacterial infection [24], and in-vivo by administering rMCP-1 i.t and determining
neutrophil numbers in the BALF following infection; C) to assess neutrophil numbers in the
circulation of MCP-1 gene deficient mice post-bacterial infection by using flow cytometry
and neutrophil specific antibody (Gr-1/Ly6G); and D) whether administration of exogenous
MCP-1 can protect the mice after gram negative bacterial infection by determining the
survival and bacterial burden in lungs, spleen, liver and blood.
This dissertation is organized and presented in five chapters. This general introduction is
followed by a review of the literature pertinent to mechanisms of neutrophil recruitment
during bacterial pneumonia. The third and fourth chapters detail the methods and results of
the original research performed over the course of my graduate program. Each of these
chapters are presented in the format required by the scientific journal in which it has been
published or to which it has been submitted. The format of Chapter 2 conforms to that of the
American Journal of Respiratory Cell and Molecular Biology in which the original article
was published. The format of Chapter 3 conforms to that of Infection and Immunity, in which
the original research was published. The format of Chapter 4 conforms to that of The Journal
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of Immunology, to which the original research has been submitted. The fifth chapter is
devoted to a general discussion of this research and its major conclusions.
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The respiratory system continually encounters microorganisms. The pathogenicity of a
microorganism not only depends on its virulence factors, but also on the host’s immune
defense and the environment. The myeloid and structural/resident cells of the respiratory
system detect invading microorganisms by binding their pattern recognition receptors
(PRRs), such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs) to bacterial
ligands. This recognition triggers a cascade of events leading to the activation of transcription
factors, production of chemokines/cytokines, upregulation of cell adhesion molecules,
phagocytic cellular infiltration and subsequent clearance of the microorganisms. The major
players of the innate immune system are neutrophils, macrophages and dendritic cells.
Dendritic cells and macrophages not only produce proinflammatory mediators but also
present antigens to induce an eventual adaptive immune response. The innate immune system
in vertebrates confers immediate defense against invading microbes via mechanisms such as
phagocytosis, whereas the adaptive immune system armed with T and B lymphocytes plays
an important role in chronic or recurrent infections.
Pneumonia is an important cause of mortality both in developed and developing
countries (1). When microbial infections overwhelm the innate immune mechanisms, the
result is pneumonia, which is associated with extensive lung pathology (1, 2). Although
pneumonia can be caused by a variety of microbes, such as bacteria, viruses and fungi, we
have primarily focused upon bacterial pneumonia in this review. The initial phase of bacterial
pneumonia is characterized by neutrophil-mediated inflammation (1, 2). While neutrophilic
inflammation aids in removal of bacteria, it also induces bystander injury to the lung. When
severe, this injury may lead to a clinical condition termed Acute Lung Injury (ALI)/Acute
Respiratory Distress Syndrome (ARDS) (1, 2). It is therefore imperative to explore the
molecular mechanisms that underlie pneumonia and ALI/ARDS in order to formulate

8

therapeutic strategies to augment host immune mechanisms to combat microorganisms while
attenuating excessive lung damage.
This review addresses our current understanding of the innate immune responses of
the host against different gram-positive and gram-negative bacteria during the acute phase of
bacterial pneumonia with special emphasis on the role of PRRs such as TLRs and NLRs,
transcription factors, cytokines and chemokines in neutrophil accumulation. Furthermore, we
discuss emerging roles for cholesterol and alcohol in neutrophil recruitment to the lung
during bacterial pneumonia.

Neutrophil Mobilization to the Lungs

A large pool of neutrophils is stored in the bone marrow. Granulocyte-colony stimulating
factor (G-CSF) stimulates the proliferation and differentiation of the granulocytic lineage in
the bone marrow into mature neutrophils. These neutrophils are mobilized to the bloodstream
during bacterial infections and are believed to be the first line defenders of the innate immune
system against microbes. Neutrophils in the bloodstream adhere to the vascular endothelium
and migrate across the endothelium to reach sites of inflammation in various organs,
including the lungs (3). This process involves multiple adhesion molecules from different
families that are expressed on the surface of endothelial cells in response to different
cytokines. As neutrophils migrate to inflammatory foci, they get activated, generate free
radicals, release granule contents, and phagocytose and degrade microbes. Neutrophils are the
first phagocytic cell recruited to a site of bacterial infection, but they have a very short life
span (<6 h) after release from the bone marrow.

Neutrophils are one of the critical contributors to host defense in the lungs since 1)
selective depletion of neutrophils results in substantial reduction in the clearance of S.
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pneumoniae, K. pneumoniae and L .pneumophila, and 2) repletion of neutrophils in
neutropenic mice improves host defense and survival in response to bacterial infection (4-6).
Although the neutrophil is the critical cell type implicated in the pathogenesis of ALI/ARDS,
its short life span renders it difficult to use genetic manipulations to investigate the signaling
cascades in response to stimuli. In this context, a novel method has recently been developed
to generate mature neutrophils from bone marrow derived progenitor cells via long term bone
marrow culture system (7). These neutrophils are mature as determined by morphology,
expression of surface markers (Gr1, CD11b, CD62L and CXCR2), and functional
capabilities, including superoxide generation, exocytosis of granular contents, chemotaxis,
phagocytosis, and bacterial killing. Furthermore, these in vitro mature neutrophils are capable
of migrating to inflammatory sites in vivo. We anticipate that this system will serve as an
important tool to advance our knowledge in neutrophil biology in the future.

Despite the fact that various animal model systems are used to delineate molecular
mechanisms underlying neutrophil accumulation and lung injury, murine models have been
used extensively because 1) bacteria can induce substantial neutrophil influx and subsequent
damage to the lungs of mice during pneumonia; 2) several mouse strains with a variety of
gene deletions or disruptions are available; and 3) there is ample availability of reagents and
pharmacological agents to dissect out the signaling mechanisms in murine models.
Recognition of Microbes
The innate immune system is responsible for recognizing invading pathogens and subsequent
initiating the inflammatory response and/or host defense. Distinguishing self from non-self is
therefore an important hallmark of the immune system. The recognition of bacteria relies on
PRRs that can recognize molecular moieties common to microbes. The discoveries of both
membrane-bound and cytoplasmic PRRs, including TLRs, NLRs, mannose receptors, and
10

RNA helicases have stimulated investigations on the biology of the innate immune system.
We have highlighted the roles of TLRs and NLRs in this review since these receptors have
recently been identified and have important roles in host defense against bacterial infections.
A single microbe generally has a variety of molecules called pathogen associated
molecular patterns (PAMPs) that can activate a single or multiple PRRs (8). The intracellular
signaling cascades initiated by these receptors may lead to the activation of numerous
transcription factors, such as those of the nuclear factor (NF)-κB, activating protein (AP)-1,
signal transduction and transcription (STAT) proteins and interferon regulatory factor (IRF)
families(8), thereby regulating the expression of pro-inflammatory mediators, such as
cytokines/chemokines, and adhesion molecules. In turn, these proinflammatory mediators can
induce infiltration of neutrophils via enhancing chemotaxis and activating neutrophils to
release more cytokines/chemokines. While neutrophils combat pathogens in a nonspecific
manner as innate immune cells, antigen presenting cells, such as dendritic cells and
macrophages, present antigens to T lymphocytes to induce antigen specific adaptive immune
response. However, recent reports have suggested that neutrophil-derived IL-18 together with
dendritic cell-derived IL-12 can induce IFN-gamma synthesis in NK cells in response to i.v.
L. pneumophila infection in mice (9). These recent findings reveal a new role for neutrophils
in the control of bacterial infection, in addition to their classical phagocytosis/microbicidal
functions.
TLRs
TLRs are type 1 transmembrane receptors, with an ectodomain composed of leucine rich
repeats (LRRs), and are members of a larger superfamily of interleukin 1-receptors (IL-1Rs).
Toll was initially identified in Drosophila as a receptor essential for dorsoventral polarity
during embryogenesis and later was shown to also be important for antifungal host defense in
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insects. The members of this family share a conserved region of ~200 amino acids in the
cytoplasmic region known as the Toll/IL-1R (TIR) domain (10) whereas the extracellular
LRR region is diverse in nature and is directly involved in the recognition of microbes.
TLRs function as dimers, usually forming homodimers except for TLR2, which
dimerizes with either TLR1 or TLR6 giving rise to different ligand specificities. To date, 12
TLRs in mice and 10 in humans have been identified (8). Several TLRs can recognize
bacteria and/or their components. For example, TLR1, TLR2, and TLR6 recognize lipid and
carbohydrate compounds, including lipoteichoic acid and lipoprotieins, from gram-positive
bacteria. TLR4 recognizes lipopolysaccharide (LPS), a cell-wall component of gram-negative
bacteria and myeloid differentiation protein-2 (MD-2) is a key molecule important for the
TLR4 recognition of LPS, whereas TLR5 recognizes bacterial flagellin. TLR3,-7,-8, and -9
are receptors for nucleic acid and its derivatives. Furthermore, TLR11 has shown to be
involved in the recognition of profilin and uropathogenic bacteria (Figure 2.1).
Several studies have unequivocally demonstrated the role of TLRs in pulmonary host defense
(Table 1 and Figure 2.1). For instance, TLR2 has been shown to be essential for host defense
against Streptococcus pneumoniae (11) and Porphyromonas gingivalis (12) , however TLR2
only mediates partial resistance to L. pneumophila (13-15). TLR4 contributes to a protective
immune response against both S. pneumoniae (16) and Klebsiella pneumoniae (17), although
its role is much more pronounced against K. pneumoniae. TLR4 also contributes to
pulmonary host defense against H. Influenza (18). And MD-2 plays an important role during
E.coli induced pneumonia (19). Both TLR2 and TLR4 have been shown to be significant for
host defense against Acinetobacter baumannii (20) and Pseudomonas aeruginosa (21). TLR5
is an important regulator of neutrophil infiltration into the lung at early time-points (6 h), but
not at late time points (24 h or beyond) during L. pneumophila infection (22). TLR9 is
required for effective host defense not only against gram-negative pathogens, such as L.
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pneumophila (23) and K. pneumoniae (24) but also gram-positive pathogens, such as S.
pneumoniae (25). These observations reveal 1) the activation of multiple TLRs in response to
bacterial infection; and 2) the time-dependent activation of TLRs in response to bacterial
interaction.

Figure 2.1: Respiratory pathogens are recognized by TLRs. Plasma membrane-bound TLRs
(TLR2, TLR4 and TLR5) and endosome-bound TLRs (TLR3, TLR7, TLR8 and TLR9)
recognize bacterial pathogens in the lungs. TLR2, TLR4, TLR5, TLR6, TLR7 and TLR9
recruit MyD88 whereas TLR2 and TLR4 recruit both TIRAP and MyD88. TLR3 and TLR4
recruit TRIF. Binding of pathogens and/or PAMPs to TLRs leads to complex signaling
cascades, which results in transcription of proinflammatory mediators. In turn, these
proinflammatory mediators, including chemokines, recruit neutrophils to the lungs during
bacterial infection.
LRRs of TLRs -2,-4,-5 &-6 are located outside of the cell while the toll-interleukin (IL)-1
receptor homology (TIR) domain is located inside the cell in all TLRs (10). Distinct adaptor
molecules, including Myeloid differentiation primary response gene (88) (MyD88), Tollinterleukin 1 receptor (TIR) domain-containing adapter protein (TIRAP), TRIF related
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adaptor molecule (TRAM), TIR-domain-containing adapter-inducing interferon-β (TRIF) and
Sterile-alpha and Armadillo motif containing protein (SARM), physically associate with the
TIR domain of TLRs in order to transduce the signals. MyD88 is important for TLRs -1,-2,4,-5,-6,-7, -8, -9, -10, and -11 mediated signaling network and it is recruited to the TLR
complex by TIRAP in TLR2 and TLR4 initiated cascades. TRIF is involved in TLR3 and
MyD88-independent TLR4 signaling. TRAM plays a key role in TRIF-dependent, MyD88independent signaling through TLR4 (Figure 2.1).
It is important to note that individual TLRs can activate overlapping as well as distinct
signaling cascades, ultimately providing diverse biological responses via activation of
mitogen associated protein kinases (MAPKs), and transcription factors, in turn resulting in
the expression of growth factors, cytokines/chemokines and cell adhesion molecules (Figure
1). For example, MyD88-dependent TLR signaling cascades lead to early NF-κB activation
whereas MyD88-independent TLR signaling pathways result in delayed NF-κB activation. Of
the TLR signaling cascades, the role of interleukin-1 receptor-associated kinases (IRAKs) in
host defense has been well established. Four different IRAKs (IRAK-1, IRAK-2, IRAK-M,
and IRAK-4) have been identified in mice and humans. Recently, patients with inherited
IRAK-4 deficiency were reported who failed to respond to IL-1, IL-18, or to stimulation with
TLR2, TLR3, TLR4, TLR5, and TLR9 agonists(26). In addition, findings with IRAK-M
gene-deficient mice have shown that IRAK-M serves as a negative regulator of IL-1R/TLR
signaling and therefore, IRAK-M knockout mice showed more neutrophils and augmented
bacterial clearance to P. aeruginosa in the lungs in a sepsis model(27).
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Table 1: Role of Immune Molecules in Acute Lower Respiratory Bacterial Infection
TLR

Phenotypea

Infection (References)
Survival

Neutrophil
Influxb

Bacterial
Burdenc

Bacterial
Dissemination
d

TLR2

Acinetobacter baumannii
(20)
Legionella pneumophila
(13-15)
Porphyromonas gingivalis
(12)
Pseudomonas aeruginosa
(21)
Streptococcus pneumoniae
(11)
TLR4
Acinetobacter baumannii
(20)
Haemophillus influenzae
(18)
Klebsiella pneumoniae (17)
Pseudomonas aeruginosa
(21)
Streptococcus pneumoniae
(16)
TLR5
Legionella pneumophila
(22 )
TLR9
Klebsiella pneumoniae (24)
Legionella pneumophila
(23)
Streptococcus pneumoniae
(25)
TLR Adaptor
MyD88
Escherichia coli (35)
Haemophilus influenzae
(31)
Klebsiella pneumoniae (6)
Legionella pneumophila
(14,33,34)
Pseudomonas aeruginosa
(32,33)
Staphylococcus aureus (32)
Streptococcus pneumoniae
(30)
TIRAP
Klebsiella pneumoniae
(6,36)
Escherichia coli (6,36)

↓

↓

ND

ND

↓

↓

↑

↑

ND

NS

↑

ND

ND

NS

↑early

ND

↓

↓

↑

↑

↓

↓

↑

↑

↓

↓

↑

ND

↓
ND

ND
↓late

↑
NS

ND
ND

↓

↓

↑

ND

ND

↓early

NS

ND

↓
↓

NS
NS

↑
↑

↑
ND

↓

NS

↑

↑

↓
ND

↓
ND

ND
↓

ND
ND

ND
↓

↓
↓

ND
↑

ND
↑

↓

↓

↑

↑

ND
↓

↓
↓

ND
↑

ND
↑

↓

↓

↑

↑

ND

↓

↑

ND
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(Table 1 Contd.)
TRIF

Escherichia coli (36)

↓

↓

↑

↑

Pseudomonas aeruginosa
(37)

ND

↓

↑

ND

Transcription Factor
Escherichia coli (48)

↓

↓

NS

ND

Streptococcus pneumoniae
(49,50)
E. coli (53)
K. pneumoniae (51)
Pseudomonas aeruginosa (52)

ND

↓

↑

ND

ND
↓
ND

↓
ND
NS

↑
↑
↑

ND
↑
ND

IL-17

Pseudomonas aeruginosa (57)
Klebsiella pneumoniae (56)
Klebsiella pneumoniae (59)

ND
↓
↓

↓
ND
ND

NS
ND
ND

NS
ND
ND

TNFα

Streptococcus pneumoniae (50)

↓

↓

↑

ND

IL-1

Streptococcus pneumoniae (50)

↓

↓

↑

ND

Pseudomonas aeruginosa (62)
Legionella pneumophila (64)
Nocadia asteroids (63)#
CXC chemokine

↓
↓
↓

↓
↓
↓

ND
NS
↑

ND
ND
ND

KC
$
MIP2 #

Klebsiella pneumoniae (65)
Klebsiella pneumoniae (65)
Nocadia asteroids (63)

↓
↓
NS

↓
↓
NS

ND
↑
NS

ND
↑
NS

Lungkine

Klebsiella pneumoniae (67)

↓

↓(24h) **
↑(48h) **

↑

ND

NF-κB
p50

STAT3
STAT4
Cytokine
IL-23

CXC chemokine receptor
CXCR2

a

Phenotype was determined mainly by using gene-deficient or mutant mice after
intrapulmonary infection and phenotypes established by transgenic mice are indicated
seperately;
b
Neutrophil influx was determined in BALF and/or Lung parenchyma;
c
Bacterial burden was measured as CFUs in the lungs;
d
Bacterial dissemination was measured as CFUs in blood or spleen;
**Signficant in airspaces but not in lung parenchyma
$ studied with transgenic mice; # Abs Only;
ND: Not Determined; NS: No significant difference
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As most of the TLR studies have been performed in murine models, the efficacy and
safety of TLR therapies may not extrapolate to human responses. This is because of 1)
differences between the human and murine immune system; 2) differences in the activation
profile of human and mouse, such as TLR8 (8), and also because 3) murine investigations are
performed on in-bred strains that have minimal genetic variation. Though TLR9 agonists,
such as CpG oligodeoxynucleotides, have been shown to protect against numerous infectious
agents in murine models(28), no human clinical studies have been reported, to our
knowledge, using TLR9 agonists in bacterial infections. In addition, TLR3, TLR7, TLR8 and
TLR9 can be activated upon intracellular bacterial infection, resulting in the production of the
IFN-α (29); these receptor agonists can be targeted to control bacterial infections.
Investigations have shown that TLR adaptor proteins play an important role in host
defense against bacterial pathogens in the lung (Table 1). For instance, MyD88 is critical for
host defense against numerous pathogens, including S. pneumoniae (25), H. influenzae (30),
P. aeruginosa (31-33), S. aureus (32), K. pneumoniae (31), L. pneumophila (14, 33, 34), and
E coli (31). Furthermore, TIRAP is reported to be essential for host defense against E. coli
and K. pneumoniae (6, 35). In addition, MyD88 gene-deficient mice show a more
pronounced phenotype as compared to single or double TLR gene-deficient mice (14, 21, 34).
Moreover, MyD88-independent, TRIF signaling has also been shown to be important for host
defense in the lungs against E. coli(35) and P. aeruginosa (36). These observations
demonstrate the 1) importance of MyD88 as an adaptor molecule for several TLRs; 2)
importance of TRIF as an adaptor molecule for TLRs and/or 3) sequential activation of
several TLRs during bacterial infection in the lungs. Our studies using a TRIF blocking
peptide to attenuate the expression of IL-8, IL-6 and TNF-α, in response to E. coli
demonstrate the importance of TRIF in humans (35). These results reveal the potential for
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using cell permeable compounds to attenuate cytokine/chemokine production and thereby
possibly be useful for reducing excessive neutrophil recruitment to the lungs.
NLRs
NLRs are the other types of PRRs involved in the innate immune system and are responsible
to detect the intracellular pathogens and/or PAMPs. NLRs regulate both inflammation and
apoptosis. To date, 22 NLR family members in humans have been reported (37). They have
been further classified into subfamilies, including NODs and Neuronal apoptosis inhibitor
protein CIITA, HET-E and TP-1(NACHT), LRR and PYD domains-containing proteins (NALPs),

the MHC Class II transactivator (CIITA), IPAF and BIRC1. NLRs are characterized by the
presence of a central NOD domain, a C-terminal LRR, and an N-terminal domain, including
CARD or the putative protein-protein interaction (PYRIN) domain (37). The LRRs of NLRs
are important for pattern recognition of microbial ligands.
Of the NODs, NOD1 and NOD2 are known to recognize bacteria and/or their components.
NOD1 and NOD2 recognize the bacterial peptidoglycan components γ-D-glutamylmesodiaminopimelic acid and muramyl dipeptide, respectively(37). The NODs interact with
microbial molecules by means of a C-terminal LRR region and activate downstream gene
transduction events through N-terminal CARD domains, which leads to apoptosis. These
receptors transmit the signals by the serine threonine kinase CARDIAK/RICK/RIP2 and
activate NF-B. Microbial molecules are detected by these proteins resulting in their
oligomerization and activation of caspases (37). Active caspases play an important role in
inflammation via cleavage and maturation of proinflammatory cytokines. Recent
investigations have shown that NOD1 is important for bacteria-induced host response. For
example, NOD1 detects P. aeruginosa peptidoglycan leading to NF-B activation. Cytokine
secretion kinetics and bacterial killing are altered in NOD1-deficient cells infected with P.
aeruginosa in the early stages of infection (38). When NOD2 and NOD1 gene-deficient
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mice were infected with E. coli, they showed reduced NF-B activation, and attenuated
cytokine/chemokines and neutrophil influx in the lungs (39). They also observed increased
bacterial burden

in the liver and spleen of NOD1 and NOD2 gene – deﬁcient

mice.
NACHT, LRR and PYD domains-containing proteins (NALPs) are the other members of

the NLR family. NALPs have a PYRIN domain instead of a CARD domain at the Nterminus. This subfamily consists of 14 proteins but most of their functions have not yet been
determined. NALP1, NALP2, and NALP3 have been involved in the cleavage of
prointerleukin (IL)-1β and proIL-18 to mature forms via caspase-1, respectively (40). These
NALPs form a complex of proteins called an “inflammasome” which comprises adaptor
proteins and caspases. NALPs have emerged as mediators of antibacterial host defense in
recent years. NALP1 has been shown to be important for host defense against Bacillus
anthracis(40). NALP3 is well studied and has been shown to be essential for host defense
against L. pneumophila (41) and Francisella tulerensis (42). IPAF is another NLR family
member. It contains CARD domains and has been shown to recognize Salmonella flagellin
and induce IL-1β production (43). Flagellin of L. pneumophila is also responsible for IPAFdependent caspase-1 activation (44). NLR family apoptosis inhibitory protein 5 (NAIP5) or
baculoviral IAP repeat containing 1e (Birc1e) is an NLR protein that regulates host
susceptibility to the intracellular pathogen L. pneumophila. NALP5 has been implicated in L.
pneumophila-induced caspase-1 activation (44). Further understanding of the molecular
pathways of NLRs in lung may lead to new strategies for controlling bacterial infectious
diseases in the lungs.
Transcription Factors
Transcription factors are sequence-specific DNA-binding proteins that bind to the promoter
or enhancer regions of specific genes and control the transfer of information from DNA to
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RNA. Although several transcription factors, including NF-B, AP-1, STAT and IRFs, play
important roles in inflammation, NF-B and STATs have been demonstrated to play
important roles in bacterial pneumonia. NF-κB, a protein complex found in almost all
mammalian cell types, is the most studied transcription factor to date. NF-κB exists in
homodimeric and/or heterodimeric forms and consists of five family members, which include
p50 (NF-κB1), p52 (NF-κB2), c-Rel, RelB, and RelA (p65) (45). All members of the family
share the Rel homology domain. NF-κB acts as a transcription factor in response to stress,
cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens.
In normal cells, NF-κB dimers are present in the cytoplasm and inhibited by IκBs (Inhibitor
of κB), proteins that contain multiple copies of a sequence called an ankyrin repeat. The IκB
proteins mask the nuclear localization signals of NF-κB proteins and keep them in an inactive
state in the cytoplasm. Degradation of IκB leads to nuclear translocation of NF-κB and its
subsequent binding to the promoters of and “turn on” expression of specific genes.
NF-κB can be activated by TLRs, NODs and NALPs and this triggers the expression
of proinflammatory genes, including different cytokines and chemokines through MyD88
dependent and independent cascades. Recently, it was found that NLRs also activate NF-κB.
Activation of NF-κB contributes to neutrophil accumulation elicited in the lungs by LPS,
which is largely in part through the upregulation of several neutrophil chemokines (KC,
MIP2, and CXCL5). Studies demonstrate that endogenous NF-κB protects the mice during E.
coli (46, 47) and pneumococcal pneumonia and is essential for the survival during these
infections (48). Neutrophil emigration to the alveoli during LPS-induced inflammation was
severely reduced in TNF Receptor 1/RelA- double knockout mice, when compared to their
control (TNFR1-deficient) mice (49). In a similar manner, it has been shown that deficiency
of TNF-α and IL-1 receptor signaling reduces NF-κB activation to S. pneumoniae (49).

20

Furthermore, TRIF-deficient mice also showed reduced NF-κB activation and chemokine
expression in the lungs during P. aeruginosa infection (36).
Although the role of NF-κB has been studied extensively in pneumonia, there are
other transcription factors, such as STATs, which also play an important role in the innate
immunity. STATS can be activated by cytokines, including IL-6. Cytokines bind to their
homodimeric or heterodimeric receptors, which can bind to janus kinases (JAK). JAKs can
be activated by transphosphorylation followed by phosphorylation of cytokine receptors,
allowing STATs to bind cytokine receptors. The activated STATs translocate to the nucleus
where they bind DNA and induce transcription of genes. Studies have shown that the STAT4
is an integral component of the host innate immune response leading to cytokine production
and bacterial clearance during K. pneumoniae infection in the lung (50). STAT4 also
contributes to P. aeruginosa induced inflammation but is not essential for bacterial
clearance(51). Furthermore, STAT1 and STAT3 contribute to neutrophil emigration during
E. coli pneumonia. During E. coli pneumonia, IL-6 family members specifically activate
alveolar epithelial STAT3 in order to promote neutrophil infiltration into the lungs (52).
Cytokines
Cytokines are polypeptides produced by variety of cell types. They have autocrine, paracrine
or endocrine functions to regulate inflammation and immune defense. Cytokines bind to their
cognate receptor and signal via second messengers, thereby increasing or decreasing the
expression of other membrane proteins and can be categorized as pro-inflammatory or antiinflammatory. TNF-α, IL-1β, IL-6, IL-8 and IFN-γ are major pro-inflammatory cytokines
which participate in acute inflammation; IL-8 acts as a chemoattractant whereas TNF-α and
IL-1β stimulate antigen presentation and increase the expression of cell adhesion molecules.
On the other hand, IL-10, TGF-β and IL-1Ra are major anti inflammatory cytokines that
down regulate the inflammatory response in the lungs(53) .
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The importance of interleukin (IL)-12 in antibacterial host defense has been widely
established. The IL-12-IFN- γ axis is known to be involved in host immune defense against
bacterial pathogens and induces cell-mediated immune responses to clear infection. However,
the role of the IL-23-IL-17 axis has only recently been recognized, as mice which lack both
IL-12 and IL-23 are more susceptible to bacterial infections (54). IL-23 is a newly described
cytokine synthesized by macrophages and dendritic cells. It shares the p40 subunit with IL12, an important cytokine in the induction of the Th1 response (e.g., IFN- γ), but has a
distinct p19 subunit. In general, IL-23 produces more IL-17 from CD4+ T cells than IL-12.
Several recent studies suggest that bacterial infection can induce IL-23 expression by
macrophages and/or dendritic cells. It has been documented that IL-23 is essential to mediate
host defense in the lungs against K. pneumoniae and P. aeruginosa (55, 56).
IL-17, which is mainly produced by T cells via the Th17 immune cascade, has been
proposed as a proinflammatory cytokine (57). Recently, five new IL-17 family members
have been identified; IL-17B, IL-17C, IL-17D, IL-17E (also named IL-25) and IL-17F (57).
Virtually all cells bear the IL-17 receptor, which has been shown to recruit neutrophils to the
lung by stimulating the production of the ELR+CXC chemokines; IL-8 or KC (a mouse
homolog of IL-8) (57), and G-CSF. In addition, IL-17A seems to be important for the early
and the late phase of neutrophil accumulation in the lungs (52). Furthermore, IL-17 can
induce the upregulation of other cytokines including IL-1β and IL-6, and ICAM-1 by several
types of cells (e.g., endothelial cells, epithelial cells) (57). Using gene-deficient mice, it has
been shown that IL-17 is important for host defense in the lungs against respiratory infection
in mice caused by K. pneumoniae (58).
Chemokines
Cytokines that act as chemoattractants for other cells are known as chemokines. Chemokines
are produced locally at sites of infection/inflammation and regulate the recruitment of
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specific subpopulations of leukocytes from the bloodstream into tissues. Chemokines
enhance neutrophil adhesion and extravasation across the post-capillary venules and direct
migration neutrophils to sites of infection/inflammation. According to the composition of a
cysteine motif located near the N-terminus of these molecules, they are categorized into the
C, CC, CXC and CX3C subgroups. These chemokines have four cysteine molecules, the first
two of which are separated by a non-conserved amino acid, and can be further categorized by
the presence of the ELR (glutamic acid-leucine-arginine) motif immediately preceding the
CXC sequence(59). All known ELR+CXC chemokines are neutrophil chemoattractants.
Seven chemokines (IL-8; NAP-2; GRO α,β and γ; ENA-78 and GCP-2) have been identified
in humans(59). Among these IL-8 is the most potent neutrophil chemoattractant in bacterial
pneumonia. Although a real homolog of human IL-8 has not been identified in rodents,
keratinocyte-derived chemokine (KC), macrophage inflammatory protein (MIP)-2, LPSInduced CXC Chemokine (LIX; CXCL5), and lungkine are important chemoattractants in
mice in response to bacterial lung infection (60).

While most chemokines are secreted by myeloid cells, lungkine and LIX are secreted
by bronchial epithelial cells and type II alveolar epithelial cells respectively. There are two
receptors identified for CXC chemokines: CXCR1 and CXCR2, which are expressed in both
humans and mice. CXCR2 binds to all ELR+CXC chemokines and is essential for neutrophil
infiltration into the lungs during bacterial infection. In this context, in vivo studies have
shown that neutrophil recruitment induced by P. aeruginosa (61), Norcardia asteroids (62)
and L. pneumophila (63) involves the CXCR2 receptor (Table 1). Regarding the CXCR2
ligands, KC, and MIP2 are important to neutrophil influx during infection, as blocking these
ligands impairs host defense (61, 64). Although lungkine is not important for neutrophil
influx into the lung parenchyma, it is important for neutrophil accumulation in the airspaces
(65) (Table 1). It has been reported that CXCL5 upregulation increases neutrophil trafficking
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during infections with P. aeruginosa, K. pneumoniae, L. pneumophila and Bordetella
bronchiseptica. Subsequent studies have shown that LIX is an important molecule for
neutrophil influx in the lungs during LPS-induced inflammation (66). However, the role of
LIX in neutrophil infiltration in the lungs during bacterial infections remains to be
determined.

Emerging Roles for Cholesterol in PMN Recruitment to the Lung
Cholesterol exerts complex effects upon the pro-inflammatory functions of macrophages,
PMNs, and other cell types.

Cholesterol-overloading induces macrophages to produce

cytokines in part through endoplasmic reticulum stress (67-69), though it may also either
enhance or attenuate macrophage responses to LPS (70, 71). Hypercholesterolemia primes
PMNs for oxidant and granule protein release (72, 73), induces PMN adhesion to and
emigration from post-capillary venules (74), and promotes mononuclear cell accumulation in
vascular lesions by inducing endothelial chemokines (75, 76). The net effect of systemic
dyslipidemia on organ-localized inflammation is likely, however, to be complex, as
cholesterol loading also impairs leukocyte chemotaxis (77), and lipoproteins, the particles
that carry cholesterol in the bloodstream, bind to and neutralize bacterial lipopolysaccharide
(LPS)(78) and inhibit leukocyte signaling responses to multiple Toll-like Receptor ligands
(79). Further complicating expectations for the net effect of cholesterol upon inflammation in
the lung in particular is the fact that the mechanism of, and requirements for PMN
transmigration from the vascular compartment into the airspace differ substantially from
those at work in other organs (3).

While little is known about either the sensitivity of lung-resident cells to systemic
dyslipidemia (i.e., circulating lipoprotein cholesterol) or the lung’s local regulatory
mechanisms for cholesterol, emerging reports interestingly do suggest that cholesterol

24

trafficking and inflammation may be coupled uniquely in the lung. For example, genetic
deletion of the cellular cholesterol efflux pump ATP Binding Cassette Transporter G1
(ABCG1) induces recruitment of multiple leukocyte subtypes, including PMNs, to the
unexposed murine lung (67, 69), responses that reflect cooperative pro-inflammatory
contributions from cholesterol-overloaded alveolar epithelium and alveolar macrophages.
Conversely, the potential for therapies that reduce cellular and serum cholesterol to reduce
PMN recruitment to the airspace has also been reported.

Three different hydroxy-

methylglutaryl coenzyme A reductase inhibitors (‘statins’) used to treat clinical
hypercholesterolemia have now been shown to reduce PMN recruitment to and microvascular
injury within the rodent lung following LPS exposure (80-82), likely due to dual effects upon
PMN chemotaxis and endothelium. Statins also enhance clearance of apoptotic PMNs by
alveolar macrophages (83). While statins do exert some effects on leukocyte function by
depleting cellular cholesterol (84), other effects stem from depletion of cellular isoprenoids
and consequent inhibition of cellular protein prenylation (80). Systemic treatment of rodents
with synthetic agonists of Liver X Receptor (LXR), a nuclear receptor that promotes cellular
cholesterol efflux and reverse cholesterol transport, has also been shown to reduce PMN
recruitment into the airspace induced by LPS and Gram-negative bacteria (85, 86).

A

potential untoward consequence of reduced PMN recruitment to the lung through cholesterol
targeting is impaired antibacterial host defense, as both statins and LXR agonists also reduce
clearance of bacteria deposited in the rodent lung (80, 86). In the case of statins, impaired
bacterial clearance may also reflect drug-induced defects in PMN bactericidal function (80).
This said, clinical expression of pneumonia and its complications reflect not only pathogen
proliferation, but also bystander tissue injury from responding host cells.
In recent years, the relationship between statin use and risk of community-acquired
pneumonia has been examined in observational studies. Several retrospective studies have
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reported that statins are independently associated with either reduced risk of pneumonia (87,
88) or reduced pneumonia-associated mortality (89-93). Prospective, randomized, controlled
trials will be necessary to resolve a potential role for statins in pneumonia therapy, however,
as a prospective cohort study of patients hospitalized for community-acquired pneumonia
reported no significant relationship between statins and a composite outcome of in-hospital
mortality or admission to an intensive care unit (94). Given these findings, it may be difficult
to conclusively rule out persistent confounding or a ‘healthy user’ effect (95). Moreover,
publication bias cannot be excluded.
The effect of cholesterol upon PMN recruitment to the lung likely depends upon the cell
types having dysregulated cholesterol, the specific molecular features of the dyslipidemic
state, and perhaps the nature of the alveolar or hematogenous insult. Contrary to the effects
of localized pulmonary cholesterol overload observed in ABCG1 deficiency, systemic
dyslipidemia induced by either diet or genetic manipulation is associated with reduced
recruitment of PMNs to the LPS-exposed airspace, reflecting both reduced airspace
chemokine expression and impaired PMN chemotaxis; dyslipidemic rodents nevertheless
have increased airspace fluid protein suggesting aggravated injury to the alveolocapillary
barrier (Fessler, unpublished observations). Collectively, these data indicate that cholesterol
has the potential to either promote or inhibit PMN recruitment to the airspaces, and may also
impact lung injury through independent, direct effects on the integrity of the air-blood barrier.
Given the high prevalence of dyslipidemia and its pharmacologic treatment in modern-day
society, further investigation of the complex effects of cholesterol upon PMN recruitment to
the lung is clearly urgently needed.
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Alcohol
Alcohol abuse has been associated with increased risk for bacterial pneumonia.
Observational data show that alcoholic men and women suffer increased mortality from
bacterial pneumonia compared to controls (96). A key element to early host defenses against
invading microbes is the robust recruitment of neutrophils into the infected lung. Extensive
work has shown conclusively shown that alcohol intoxication interferes with both the
recruitment and functional capacity of neutrophils during bacterial infection of the lower
respiratory tract (97-100).
The early expression of “alarm” cytokines, such as TNF-α by alveolar macrophages is
central to the development of the histologic hallmark of bacterial pneumonia: neutrophil
infiltration (101, 102).

Acute alcohol intoxication impairs lung TNF-α production in

response to LPS at the post-transcriptional level (103, 104). By impairing the co-localization
of TNF-α and the cell-surface bound TNF-α converting enzyme (TACE), acute ethanol
exposure prevents cleavage of TNF-α from the producing cell’s surface(105). The effect of
chronic ethanol exposure on TNF-α release is controversial. While some work suggests
chronic intoxication increases TNF-α release via augmented TACE activity (106) and
stabilization of TNF-α mRNA(107), other studies show suppression of TNF- α production
resulting from chronic alcohol (108, 109).
Although TNF-α is not itself a chemoattractant for neutrophils, it stimulates lung
expression of CXC chemokines, which in turn promote the recruitment of neutrophils from
the vasculature. Animal models of infection have shown that acute alcohol intoxication
suppresses the lung’s expression of the neutrophil chemokines MIP-2 and CINC, rodent
orthologues of the human neutrophil chemokines IL-8 and Gro-α, which bind the CXCR2
receptor found on neutrophils (100, 110). This suppression is accompanied by decreased
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neutrophil recruitment, and exogenous chemokine administration has shown promise in
restoring intrapulmonary neutrophil influx (111). The expression of neutrophil chemokines
comes from many cell types in the lung, including the alveolar epithelium (112). Taken
together, this suggests that alveolar parenchymal cells may be susceptible to alcohol. We
recently investigated this hypothesis by examining the effect of acute intoxication on
pulmonary expression of LIX, a neutrophil chemoattractant whose expression is limited to
alveolar type II epithelial cells(113). Ethanol exposure decreased LIX expression in response
to airway endotoxin challenge in vivo, and ethanol exposure downregulated LIX in a dosedependent manner in primary cultures of type II alveolar epithelium (114). These cells
showed inhibition of NF-κB and p38 MAP kinase pathways in response to relatively low
(25mM) ethanol concentrations, suggesting they are exquisitely sensitive targets of ethanol.
In addition to the effects of ethanol on the lung epithelium, Zhang et al. have shown that
acute ethanol intoxication profoundly suppresses the expression of the neutrophil chemokines
S100A8 and S100A9 by leukocytes (115).
In addition to decreased chemokine expression, alcohol exposure results in intrinsic
defects in neutrophils that impede migration. During pneumonia, circulating neutrophils upregulate the β2-integrin adhesion molecule, CD11b/CD18. CD11b/CD18 mediates neutrophil
firm attachment to the pulmonary capillary endothelium and their subsequent transendothelial migration. Alcohol inhibits the up-regulation of CD18 expression on neutrophils
in response to inflammatory stimuli (116) and suppresses neutrophil adhesion to the
endothelium during appropriate stimulation (117). Furthermore, studies of neutrophils taken
from chronic alcohol abusers show that these cells are hypo-responsive to chemotactic stimuli
(118, 119). In alcoholics with liver disease, it has been proposed that systemic LPS exposure
(through increased intestinal permeability and portal blood LPS content) induces a chronic
inflammatory state. Neutrophil chemokines (IL-8) and chemotactic complement fragments
28

(such as C5a) are elevated in the peripheral circulation of patients with alcoholic liver
diseases (120, 121). The chronic in vivo activation of neutrophils has been postulated to
account for the blunted response of neutrophils to chemoattractants in these hosts.
Compounding this recruitment defect, alcohol-exposed neutrophils are less capable of killing
bacteria owing to abnormalities in phagocytosis, degranulation, and superoxide generation
(122, 123).
Alcohol abusing patients are frequently leukopenic and they often do not mount an
appropriate leukocytosis during pneumonia (124). Given the importance of neutrophils in
pathogen clearance, it is not surprising that neutropenia in the alcoholic increases mortality
from pulmonary infection, particularly bacteremic pneumococcal pneumonia (125). During
bacterial pneumonia, the lung expresses G-CSF (126, 127). In contrast to most cytokines,
which are “compartmentalized” within the lung during infection, G-CSF readily exits the
pulmonary tissue and enters the circulation during infection (126, 128). G-CSF thus serves as
a means of communication between the infected lung and bone marrow (129). Studies of
systemic and pulmonary infection have shown that acute alcohol inhibits the expression of GCSF (130), and animal studies have shown that recombinant G-CSF treatment can partially
restore lung neutrophil recruitment in response to a bacterial stimulus (131). Examination of
bone marrow from chronic alcoholics often shows hypocellularity, maturation arrest, and
vacuolization of myeloid progenitor cells (132, 133).

Bone marrow cells treated with

clinically relevant ethanol concentrations show impaired granulocyte colony formation, also
suggesting a direct toxic effect on these tissues (134, 135). In the context of bacterial
infection, we have recently shown that alcohol inhibits the increase in granulopoietic
progenitor cell proliferation in mice challenged with E. coli (136). This effect is at least
partially due to alcohol preventing the phenotypic reversion of hematopoetic precursors to a
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less-differentiated state, a phenomenon described in hematopoetic precursors (129) which
appears requisite for optimal granulocyte production.

The discovery of IL-17 has broadened our understanding of how the lung solicits
neutrophil influx during infection. A product of T lymphocytes and related cell types, IL-17
induces CXC chemokine production which promote neutrophilic inflammation (137). In
animal studies, inoculation with K. pneumoniae induces a TLR4- dependent pulmonary IL-17
expression within 12 hours, and animals deficient in the receptor for IL-17 show enhanced
mortality from infection (138). Chronic alcohol intoxication inhibits IL-17 secretion in the
lungs in response to K. pneumoniae, and in vitro stimulation of T cells confirms a dosedependent inhibition of IL-17 by ethanol (139). IL-23 is induced in alveolar macrophages and
myeloid dendritic cells during challenge and is the dominant trigger for IL-17 (140). The
expression of IL-23 in the lung during bacterial challenge is strongly suppressed by acute
ethanol intoxication (55). By pre-treating animals with an adenoviral vector encoding IL-17
prior to K. pneumoniae inoculation, neutrophil recruitment is restored and survival improved
in alcohol-treated animals, suggesting transient pharmacologic gene expression therapies may
offer promise in the treatment of immunosuppressed patients with bacterial pneumonia (55).
A product of NK T cells, invariant NK T (iNKT) cells, gamma delta T cells, and CD4+ T
cells, IL-17 induces CXC chemokine production, which promote neutrophilic inflammation
(58, 137, 141, 142). While the precise source(s) of lung IL-17 expression during acute
bacterial infection are not known, work has shown that depletion of CD4+ or CD8+ cells
results in a decrease in lung IL-17 expression as expressed during Klebsiella infection. It is
likely that several of these cell populations each contribute to the IL-17 response to infection.
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Concluding Remarks

Bacterial pneumonia is an important disease. Neutrophils are one of the first cells to reach the
site of bacterial infection. An ideal therapeutic strategy would be to attenuate the tissue
destructive potential of neutrophils without reducing their efficacy in antibacterial defense.
Theoretically, one-way to do this may be to identify therapeutic targets to attenuate excessive
neutrophil accumulation during bacterial pneumonia. Our understanding of the molecular
mechanisms that regulate neutrophil recruitment during infection/inflammation has improved
substantially over recent years. Emerging studies indicate complex roles for cholesterol in
neutrophil recruitment and it has also been shown that alcohol affects neutrophil recruitment
to the lungs during pneumonia. Although antibiotics are the rational treatment for
pneumonias, antibiotic-resistant S. pneumoniae, H. influenzae, and S. aureus have been
isolated from patients suffering from lower respiratory tract infections. The emergence of
antibiotic-resistant pulmonary bacteria and the growing number of immunocompromised
individuals have made the treatment of these infections increasingly difficult. The future
challenge will be to apply our current understanding of neutrophil function to design
therapeutic methods to maintain the host defense potential of neutrophils while modulating
their destructive potential. In this context, therapeutic potential of TLRs and NLRs remains to
be explored.
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Introduction

Bacterial pneumonia is a leading cause of death in both immunocompromised and
immunocompetent individuals (12, 25, 33). Successful host defense against bacterial
infection in the lung is dependent on effective recruitment of phagocytes into the alveolar
space. During cellular recruitment, neutrophil infiltration is the first event followed by
monocyte/macrophage accumulation at the site of infection. Several lines of evidence suggest
that cytokines/chemokines regulate leukocyte migration in concert with cell adhesion
molecules, including ICAM-1 and VCAM-1 (1, 11, 32). In this context, monocyte
chemoattractant protein 1 (MCP-1/ chemokine [C-C motif] ligand 2 [CCL2]) has been shown to
be a potent monocyte/macrophage and T cell chemoattractant in lung infection against
bacteria (10, 31, 34, 35, 39, 49). MCP-1 is produced by a variety of cells, including epithelial
cells (41), endothelial cells, fibroblasts (42), and monocytes/macrophages(48) and it binds to
the G-protein–coupled transmembrane receptor CCR2.
Prior studies have unequivocally demonstrated the important role of MCP-1 in
monocyte/macrophage-mediated

host

defense

against

bacterial

infection.

During

Streptococcus pneumoniae infection, overexpression of MCP-1 has shown to improve
bacterial clearance (46). Using MCP-1-/- mice, Winter et al. (45) have demonstrated that
MCP-1-mediated macrophage recruitment is important to prevent bacterial dissemination
following pulmonary Streptococcus pneumoniae infection. During Pseudomonas aeruginosa
infection, MCP-1 promoted resolution and repair of the lung by enhancing the uptake of
apoptotic neutrophils by alveolar macrophages (2). In addition, mice deficient in CCR2
showed impairment in macrophage migration and clearance of bacteria from the lungs and
extrapulmonary organs after i.v. challenge with Listeria monocytogenes (24). MCP-1 is also
shown to be important for the survival of mice during P. aeruginosa and Salmonella
typhimurium infections and MCP-1 promotes bacterial killing by macrophages (35).
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MCP-1 is further implicated in cellular trafficking to the inflamed lung via multiple
mechanisms. MCP-1 modulates the expression of β2 integrin and thereby triggers firm
monocyte adhesion to the inflamed endothelium (28). Studies have shown that CCR2 plays
an essential role in the induction of adaptive arms of the immune system via the induction of
Th1 cytokines (10). However, the role of MCP-1 in neutrophil recruitment is debatable and
the role of MCP-1 in neutrophil recruitment during E. coli infection of the lungs is not
studied. In one study, it has been shown that administration of exogenous MCP-1 alone did
not cause neutrophil influx into the lungs whereas administration of MCP-1 along with LPS
did cause excessive neutrophil recruitment (29). In another investigation, it has been
demonstrated that neutrophils express CCR2 and chemotax towards MCP-1 (21). However,
the role of MCP-1 in neutrophil trafficking and activation in the lung in acute bacterial
pneumonia has not been studied.

The objective of the current investigation was to determine the role of MCP-1 in
neutrophil-mediated host defense following E. coli infection. In this regard, we used MCP-1
gene-deficient (MCP-1-/-) mice. Our findings demonstrate MCP-1 is induced upon E. coli
infection and can be produced by both myeloid and non myeloid cells. MCP-1 contributes to
bacterial clearance in the lungs via neutrophil recruitment in a murine model. Our findings
indicate that MCP-1 causes neutrophil recruitment to the lungs directly via chemotaxis as
well as indirectly via modulating the levels of KC and MIP-2 following E. coli infection.
Furthermore we show that neutrophils from blood and BALF express CCR2 and it is
increased upon E. coli infection.

Materials and Methods
Mice: Eight to 10-wk-old female mice genetically deficient in MCP-1 (16) or MD-2 (9)
were used while age- and gender-matched C57Bl/6 mice were used as controls. All animal
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studies were approved by the Louisiana State University and National Jewish Health Animal
Care and Use Committees. The mice ranged from 19 to 25 g in weight.

Infection Model: Bacteria were prepared for mouse inoculation, as described in previous
studies (8, 22). E. coli (American Type Culture Collection (ATCC) 25922) was grown in
trypticase soy broth (TSB) at 37°C overnight under constant agitation. Bacteria were
harvested, washed, and resuspended in sterile 0.9% saline at a concentration of 20 X10 6
CFU/ml. Mouse strains were anesthetized with i.p. ketamine/xylazine (250 mg/kg), followed
by intratracheal (i.t.) inoculation of 50 µl of bacteria (10 6 CFU/mouse) whereas control mice
were i.t. inoculated with 50 µl of saline. The initial mouse inoculums were confirmed by
plating serial 10-fold dilutions on MacConkey and tryptic soy agar (TSA) plates. For
enumerating bacterial CFU in the lung and spleen, whole lungs and spleens were
homogenized in 2 ml sterile saline for 30 s, and 20 µl of the resulting homogenates were
plated by serial 10-fold dilutions on MacConkey and TSA plates. In a similar manner, spleens
were homogenized for 15 s for bacterial culture. Bacterial colonies were counted after
incubation overnight at 37oC. For CFU studies, we used a higher dose of E. coli (5 X106
CFU/50 l/mouse) since low dose (106 CFU/mouse) did not induce substantial mortality
either in MCP-1-/- or WT mice.

Lung Pathology: The lungs were perfused from the right ventricle of heart with 10 ml
isotonic saline at 24 h post infection from WT and MCP-1-/- mice. Lungs were then removed
and fixed in 4% phosphate-buffered formalin. Fixed tissue samples were processed in
paraffin blocks, and 5 μm sections were cut with a microtome and stained with hematoxylin
and eosin (H&E). Analysis of histopathology was performed in blinded fashion by a
Veterinary Pathologist according to the following scoring scale: 0, No inflammatory cells
(macrophages or neutrophils) present in section; 1, <5% of section is infiltrated by
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inflammatory cells; 2, 5–10% of section is infiltrated by inflammatory cells; and 3, >10% of
section is infiltrated by inflammatory cells.
Bronchoalveolar Lavage Fluid (BALF) Collection: BALF was collected and total and
differential cell counts and cytokine/chemokine levels were determined. Approximately 3 ml
of lavage fluid was retrieved per mouse. Total leukocytes in BALF were determined using a
hemocytometer. Cytospin samples were subsequently prepared from BALF cells and stained
with Diff-Quick (Fisher). Differential cell counts were determined by direct counting of
stained slides. For examination of cytokines/chemokines, the remainder (2 ml) of the
undiluted cell-free BALF was passed via a 0.22-µm filter and used immediately or stored at 80oC.

Bone Marrow Transplantation :Bone marrow chimeras were generated as described earlier
(7, 9) . Recipient mice were γ irradiated from a cesium source in two 525-rad doses 3 hours
apart. Bone marrow cells (8X106/mouse) from donor mice were injected into the tail vein of
the irradiated recipients. Transplanted mice were maintained on 0.2% neomycin sulfate for
the first 2 weeks. The reconstituted mice were used 2 months after the transplantation. In
parallel experiments, we used green fluorescent protein–expressing donor cells. Sample blood
was collected from these recipients between 6 and 8 weeks after transplantation, and
hematological parameters (differential counts) were assessed. Greater than 90% of blood
leukocytes were derived from donor mice at the time the mice were used for experiments (8
wk after transplantation; data not shown). Irradiated mice that were not transplanted with
donor cells died between Days 20 and 22 after transplantation (data not shown).

Cytokine, Chemokine and LTB4 Determination: We used BALF and lungs that were
obtained from animals after E. coli infection or saline instillation. ELISA kits for TNF-α, IL6, LTB4 and MCP-1 were obtained from eBiosciences, PA whereas kits for KC and MIP-2
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were obtained from R&D systems, MN. The minimum detection limit is 8 pg/ml cytokine
protein whereas the detection limit for LTB4 is 13.7 pg/mg/ml.
Western Blotting: The lungs were collected at the designated time points and used for
Immunoblotting as described in our previous publications (8). The primary Abs to phosphoNF-B/p65(ser 536), NF-B/p65, phospho-IKK (ser 176/180), IKK, phospho-IBser
32), IB, VCAM-1, ICAM-1, phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204), phosphop38 MAPK (Thr180/Tyr182), phospho-JNK (Thr183/Tyr185), p47phox, p67phox and iNOs
were obtained from Cell Signalling, Boston, MA, and were added at a 1:1,000 dilution. The
primary Abs to total p38 and GAPDH (Santa Cruz Biotechnology, CA) were added at
1:5,000 dilution. Immunostaining was performed using appropriate secondary Ab at a
dilution of 1:2,000 and developed with ECL plus Western blot detection system (Amersham
Pharmacia Biotech, Piscataway, NJ). To demonstrate equal protein loading on gels, the blots
were stripped and reprobed with Ab specific for total p38, pan Cadherin or GAPDH.
NF-κB DNA Binding Assay: Nuclear proteins were extracted from 50-80 mg lung tissue
collected at 6 and 24 h post-E. coli or saline administration. A total of 7.5 μg nuclear extract
was mixed with binding buffer, added to the precoated plate (with the DNA binding motif of
NF-κB) and incubated for 1 h at room temperature according to manufacturer’s protocol
(TransAM ELISA kit from Active Motiff, Carlsbad, CA). Wells were then washed and
plates were incubated with NF-κB/p65 antibody for 1 h. Plates were then washed three times
and HRP-conjugated anti-rabbit IgG was added to each well and incubated for 1 h. Plates
were read at 450 nm after adding the developing reagent. This method has been described in
our earlier publications (8, 9, 22).

Neutrophil Transmigration Assay. Chemotaxis assays in a Transwell system were
performed using 24-well tissue culture plates treated polycarbonate membrane polystyrene
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plates (3415, Costar, Corning Inc. NY) with a pore size of 3.0 μm. Chemoattractants, either
KC (2μg/ml, 1 μg/ml) or MCP-1(2 μg/ml) (R&D, Minnestota, MN), and PBS supplemented
with bovine serum albumin (2 μg/ml) were added to each of the lower wells (500μl final
volume). A 100-μl suspension of 1X 106 LPS activated PMN in DMEM 0.1%BSA was added
to each well of the upper filter plate. After incubation at 5% CO2 at 37 °C for 3h, the upper
plate was removed, and cells in the lower plate were counted from 20 non overlapping fields
by using inverted microscope (18, 19).

Examination of CCR2 Expression on Neutrophils. A total of 50 µl of whole blood or
BALF of WT and MCP-1-/- mice treated with saline or E .coli was aliquoted into flow
cytometry tubes and Fc blocked and10 µl of mouse conjugated anti-mouse Gr-1, CCR2, and
CXCR-2 (R&D, Minnestota,MN) antibodies were added to appropriate tubes. Samples were
vortexed and incubated for 30 min at room temperature in dark. Then cells were washed by
adding 2 ml of 1X PBS and centrifuged at 1000 rpm (200 x g)/8 min. RBC was lysed using 2
ml of NH4Cl lysing buffer to each sample tube, mixed well and incubated at room
temperature for 10 min. Then samples were centrifuged immediately at 1000 rpm (200 x g)/8
min and the supernatant was removed. Cells washed twice with PBS. Cells were fixed by
adding 200 µl of cold 1% formaldehyde-PBS and stored at 1-6 o C for FACS analysis.
Neutrophil Depletion: The protocol used to deplete neutrophils (Gr1+) in mice has been
described in our earlier reports with minor modifications (7). A total of 50 µg anti-Gr1/Ly6G
mAb (Sodium azide- free and low LPS content; 1A8 BD pharmingen, San Diego, CA) in 250
µl was administered i.p. at 12 and 2 h before bacterial infection. In control experiments, 50µg
of isotype control mAb in equal volumes was administered at the same time points prior to
bacterial infection. To validate the efficiency of neutrophil depletion by the antibody, we
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obtained differential WBC counts in blood every 12 h up to 3 days, and ≤ 3% neutrophils
were found up to 3 d after depletion.

AM Culture: AMs were isolated as described in earlier publications (7). Positive selection
by CD11b MicroBeads (stem Cell Technologies, Vancouver, British Columbia, Canada) was
applied to isolate AMs from BAL cells. Pooled BAL cells were resuspended in RoboSep
buffer, and CD 11b PE labelling reagent was mixed with cell suspension, followed by
incubation at room temperature for 15 min. EasySep PE selection mixture was thereafter
added to the cell suspension, and the suspension was further incubated for 15 min at room
temperature. EasySep Magnetic nanoparticles were lastly mixed with the cell suspension,
followed by magnetic separation of CD11b+ cells. Cells were washed with PBS, centrifuged
at 1200rpm for 10 min, and resuspended in DMEM containing 5% FBS. Cells were infected
with E.coli (MOI of 1) and harvested at designated time points using urea/CHAPS/Tris
buffer. Samples were centrifuged and supernatants were used for western blotting. Finally,
the total number of live cells and the percentage of purified AMs were determined by
utilising trypan blue exclusion and cytospin preparations stained with Wright-Giemsa,
respectively. Percentage recovery of AMs was calculated as the ratio of AMs to the total
macrophages isolated from the BALF. Using this technique, we obtained ~85-90% AMs.

Statistical Analysis: Data are expressed as mean + SE. The intensity of immunoreactive
bands was determined using a Gel Digitizing Software (UN-SCAN-IT gelTM) from Silk
Scientific, Inc, Utah, USA. Data were analyzed by ANOVA followed by Bonferroni’s post
hoc analysis for multiple comparisons. All statistical calculations were performed using
InStat software and GraphPad Prizm 4.0. Differences were considered statistically significant
at *P<0.05 when compared with control.
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Results

MCP-1 is Essential for Bacterial Clearance Following E. coli Infection. We used an
experimental model of pulmonary E. coli infection to demonstrate the MCP-1 protein
expression in BALF and lung homogenates. MCP-1 levels were
A
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increased at 6 and 24 h in BALF (Fig. 3.1A) and the lungs of WT
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(C57Bl/6) mice (Fig: 3.1B) compared to their saline-challenged
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animals after i.t. E. coli (106/mouse) infection (Fig: 3.1A-B).
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Figure 3.1. A-B. Kinetics of MCP-1 production. MCP-1
concentration was measured in BALF (A) and lung
homogenate (B) from WT mice by ELISA after i.t. infection
with E. coli (106/mouse). Asterisks indicate significant difference
between MCP-1-/- and WT mice (p<0.005; n = 4-5
mice/group/time-point and the figure is a representation of 3
individual experiments). MCP-1 expression in mice transplanted
with bone marrow following E. coli infection (C). *indicates
significant difference between KO and WT mice; p<0.005. Data
shown is a representation of 3 individual experiments.
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In order to determine the cell type that can produce MCP-1 during

E. coli infection, we used chimeric MD-2-/- mice and infected with E. coli. 24 h post
infection. We found that both myeloid and non myeloid cell-derived MD-2 is important to
produce MCP-1 following E. coli infection (Fig: 3.1C). To determine whether a deficiency
in MCP-1 compromised host defense against E .coli in the lung, mice were infected with i.t.
E. coli (1X106 CFU/mouse) and sacrificed at 6 and 24 h post-infection. The lungs and spleens
were isolated to determine the bacterial CFU. MCP-1-/- mice had greater numbers of CFU in
the lung at 6 and 24 h post-infection (Fig: 3.2A). However, we did not observe bacterial
dissemination in the bloodstream in either MCP-1-/- mice or their controls at 6 or 24 h (data
not shown). Since we observed higher bacterial burden in MCP-1-/- mice both at 6 and 24 h
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following regular dose of E. coli (1X106/mouse) infection (Fig. 3.2A), we chose to use the
regular dose in the rest of our experiments.

MCP-1-/- Mice Show Attenuated Cellular Recruitment to the Lung following E. coli
Infection. Leukocyte recruitment to the site of infection is a critical step to clear bacteria.
Therefore, we determined the total as well as differential leukocyte count in BALF at 6 and
24 h post-infection with the regular dose (1X106 CFU/mice) (Fig. 3.2B-C). We observed
reduced leukocyte influx at 24 h post-infection in MCP-1-/- mice and this reduction was
primarily due to reduced neutrophil influx although macrophage numbers were reduced at
this time (Figs. 3.2B-C). Furthermore, attenuated leukocyte numbers and alveolar edema was
noted in lung histology of MCP-1-/- mice at 24 h. i.e., lungs from WT mice infected with E.
coli show a score of 2 (average of 3 mice) whereas lungs from MCP-1-/- mice infected with
bacteria show a score of 1 (average of 3 mice) (Fig. 3.2D). These findings show that MCP-1
is important for the neutrophil accumulation in addition to macrophage influx during E. coli
infection.
MCP-1 Regulates the Production of Cytokine/chemokines and Expression of Cell
Adhesion Molecules. Leukocyte recruitment during infection is a multistep process in which
cytokine/chemokine production along with up regulation of cell adhesion molecules plays an
important role. Hence, we used BALF to determine cytokine/chemokine levels following E.
coli infection. Our data demonstrate that levels of cytokines, such as TNF-α and IL-6 (Figs.
3.3A-B) and neutrophil chemoattractants, such as KC and MIP-2 (Figs. 3.3C-D) were
reduced at 24 h following E. coli infection in MCP-1-/- mice. We also examined the
expression of the neutrophil chemotactic lipid LTB4 in the lung of MCP-1-/- mice following
E. coli administration and found that the levels of LTB4 were decreased in MCP-1-/- mice at 6
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h, but not at 24 h (Fig. 3.3E). Although ICAM-1 expression in the lung remained unchanged,
the VCAM-1 expression was substantially reduced in MCP-1-/- mice at 24 h after infection
with E. coli (Fig. 3.3F-H). Our data suggest that MCP-1 controls the expression of cytokines,
neutrophil chemoattractants and cellular adhesion molecules.
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Figure 3.2. Bacterial clearance and leukocyte recruitment in the lungs of MCP-1-/- mice
following E.coli infection. A. Bacterial burden in the lung of MCP-1-/- mice following E. coli
infection (106/mouse). Lungs were collected from control and infected group of mice at the
designated times, homogenized and the number of bacteria were enumerated (n=5-6
mice/group). *indicates significant difference between KO and WT mice; p<0.005. Data
shown is a representation of 3 individual experiments. B-C. Cellular infiltration in the lung in
MCP-1-/- mice against E. coli. Mice were inoculated with E. coli (106 CFU/mouse), BALF
was obtained at 6 and 24 h post-infection, and cell enumeration was performed to determine
neutrophil and macrophage infiltration to the lung (n=4-5 mice/group; p<0.005, data are a
representation of 3 individual experiments). D. Lung histology in MCP-1-/- mice following E.
coli infection. Mice were inoculated with E. coli (106 CFU/mouse), lungs were obtained at 24
h post-infection. This picture is a representative of 3 separate mice with comparable results.

MCP-1 Activates NF-B, MAPKs in the Lung following E. coli Infection. NF-κB and
MAPK regulates the expression of multiple proinflammatory genes in the inflammatory
setting. We therefore investigated the activation of NF-B and MAPKs in the lungs after E.
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coli infection. Our findings demonstrate that NF-B activation was reduced in MCP-1 -/- mice
at 24 h post-infection (Figs. 3.4A-G). In
addition, MCP-1-/- mice infected with E.
coli showe d reduced activation of p38
and ERK kinases at 24 h (Figs. 3.5A-B)
whereas JNK activation is reduced at
earlier time point (6 h) in MCP-1-/mice (Figs. 3.5A-B).

Figure 3.3. A-E. Cytokine, chemokine
and chemotactic lipid/LTB4 levels in
the lung following E. coli infection.
Mice were infected by intratracheal
instillation of E. coli (106 CFU/mouse),
and BALF was collected from the lungs
at designated time points.
Concentrations (pg/ml) of TNF-α (A),
IL-6 (B), KC (C) and MIP-2 (D) in
BALF were quantified by sandwich
ELISA. Asterisks indicate significant
-/difference between MCP-1 and WT mice (p<0.005; n = 4-6 mice in each group at each
time-point and the data are a representation of 3 separate experiments). E. Expression of
LTB4 in the lung following E. coli infection. Lung homogenates were prepared after E. coli
infection, the levels of LTB4 were measured in homogenates and were normalized against
total protein concentration. F. Expression of ICAM-1 and VCAM-1 in the lung in response
to E. coli challenge. infected lungs were homogenized, total proteins were isolated, resolved
on SDS-PAGE gel and transferred onto a nitrocellulose membrane. The membrane was
blotted with Abs for ICAM-1, VCAM-1 and GAPDH. This is a representative blot of 3
independent experiments with similar results. G-H. Densitometric analysis was performed in
3 blots to demonstrate the expression of ICAM-1 and VCAM-1 in the lung following E. coli
infection
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Figure 3.4. A-B. Activation of NF-B in the lung following infection with E. coli. Lung
homogenates and nuclear lysates from MCP-1-/- mice and their controls were prepared at 6
and 24 h after infection with E coli. NF-B binding assay was performed in nuclear lysates
from lung (A) and expression and phosphorylation of NF-B pathway members were
determined using Western blots of lung homogenates (B). The blots are representative of 3
independent experiments with comparable results. C-G. Relative densities normalized against
GAPDH are representatives of 3 independent experiments. OD, optical density; encircled P,
phosphorylated form; *, P < 0.005.

55

A
℗ERK
℗ p38

℗ JNK
Total p38
Saline E. coli E. coli
24 h
6h
24 h

B

gure 3.5. A. Activation of MAPKs in the lung following E.
coli infection. Total proteins in the lung were isolated from
MCP-1-/- and control mice at 6 and 24 h after infection with
E. coli, resolved on an SDS-PAGE and the membrane was
blotted with the Abs against activated/phosphorylated form
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B. Densitometric analysis of MAPK activation was
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Recombinant MCP-1 (rMCP-1) Induces Neutrophil Influx and Cytokine/chemokine
Expression in the Lungs of MCP-1-/- Mice during E. coli Infection. Since MCP-1
deficiency causes attenuated neutrophil influx, we determined whether reconstituting MCP-1/-

mice with exogenous rMCP-1 prior to E. coli infection can cause neutrophil accumulation

and cytokine/chemokine expression in the lungs. In this regard, MCP-1-/- and WT mice were
i.t. infected with E. coli at 1 hour after i.t. rMCP-1(10 μg/mouse) administration. At 24 hours
after infection, neutrophil count was increased in BALF of MCP-1-/- mice which received
rMCP-1 (Figs.3.6A-B). Furthermore, MCP-1-/- mice reconstituted with rMCP-1 showed

56

increased expression of cytokines (TNF- and IL-6) (Figs. 3.6C-D), and chemokines (KC,
MIP-2) (Fig. 3.6E-F) in BALF after E. coli infection. Moreover expression of VCAM-1 and
activation of NF-B and MAPKs was increased in the lungs of MCP -/- mice reconstituted
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G. Numbers of CFUs in the Lung of WT and
MCP-1-/- mice after treatment with rMCP-1
following i.t. E. coli infection. The controls
were treated with PBS. N=5-6 mice/group and
the result shown is representative of 3
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Numbers of CFUs in the Lungs of neutrophildepleted mice at 24 h after E. coli infection.
Neutrophils were depleted by using anti Ly6G
Ab intraperitoneally at 12 and 2 h prior to
infection and control mice were treated with
isotype Ab prior to infection. Lung samples
were homogenised, diluted and plated to
enumerate
bacterial
CFUs.
(n=5-6
mice/group/time-point and are from 3 separate

0

D

TNF-

E

*

150

100

C

with rMCP-1 (Fig. 3.7A-C).
-/-

200

*

*

Infected

*
CFU/Lung (Log)

10

0

Legend
Legend
MCP-1

Legend
C57Bl/6
Legend

5
4
3
2
1
0

experiments). *, P < 0.05.
Since our findings show that rMCP-1 induced cytokine/chemokine secretion and
neutrophil influx in the lungs, we wanted to determine whether rMCP-1 treatment affects
bacterial clearance from the lungs. We reconstituted MCP-1-/- mice with rMCP-1 prior to
infection and lung CFUs were enumerated at 24 h post infection. MCP-1-/- mice treated with
rMCP-1 show reduced CFUs in the lung comparable to wild-type mice (Fig: 3.6G). These
observations indicate that rMCP-1 improves E. coli clearance in the lungs. In order to
57

determine whether neutrophils are important for bacterial clearance, we depleted neutrophils
in wild-type mice and challenged them with E. coli. We observed a substantial increase in the
bacterial burden in the lungs of neutrophil-depleted mice as compared to control mice (Fig:
3.6H). These findings illustrate the importance of neutrophils in E. coli clearance from the
lungs.
As we found that rMCP-1 causes neutrophil recruitment to the lungs of CP-1-/- mice
following infection, we determined whether administration of exogenous rMCP-1 in MCP-1-/mice can cause neutrophil recruitment in the absence of E. coli infection. In this regard, it has
been shown that i.t. administration of 50 μg rMCP-1 in Balb/C mice did not cause any
neutrophil influx (29). In our experiments, 2 doses of (10μg or 50μg/mouse) rMCP-1 were used
in C57BL/6 mice via i.t. route and found that the neutrophil count was increased in BALF and
lungs (Fig: 3.8A) of the rMCP-1 treated
mice in a concentration-dependent manner.

Figure. 3.7. (A) Activation of NF-κB and
MAPKs, and expression of cellular
adhesion molecules in lungs of mice
administered rMCP-1 (10µg) at 24 h
after E. coli infection. (B and C)
Densitometric
analysis
of
expression/phosphorylation
levels
of
identified proteins normalized with
GAPDH. The results are representative of
3
independent
experiments
with
comparable results. *, P < 0.05; encircled
P, phosphorylated form.
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Neutrophils Migrate Towards rMCP-1 In Vitro. Since rMCP-1 can rescue neutrophil
accumulation in MCP-1-/- mice in the presence or absence of E. coli infection, we examined
whether this is due to the direct chemotactic effect of MCP-1. In this regard, we first used
flow cytometry to determine whether neutrophils express CCR2. For these experiments,
BALF and blood obtained from WT mice after E. coli infection were used since chemokines
produced in the lungs after infection can induce neutrophil release from the bone marrow to
blood. In this regard, we used dual staining of Gr-1/Ly6G-FITC/CCR2-APC to enumerate
CCR2 expression on neutrophils. We first gated neutrophils based on their size and
granularity and then determined the double positive cell population from the gated population
of neutrophils. Notably, neutrophils in BALF and blood express CCR2 and this expression is
enhanced during infection (Fig: 3.8B). In addition bone marrow neutrophils also express
CCR2 and it is induced upon E. coli infection (Fig: 3.8C).
Since we observed CCR2 expression on neutrophils, we examined whether these
neutrophils chemotax towards MCP-1. In this context, transwell transmigration assay was
used in which we used 1X106 LPS activated neutrophils in DMEM 0.1% BSA. KC was used
as a positive control at two different concentrations (500 ng, 1000 ng) whereas MCP-1 was
used at 1000 ng. Neutrophils chemotax towards MCP-1 (Fig: 3.8D-E) although the number of
cells that chemotax towards MCP-1 is much less than the number of cells that chemotax
towards KC at the same concentration. Interestingly, neutrophils that are challenged with E.
coli produce MCP-1 at 2 h post-infection (Fig: 3.8F). These findings demonstrate that
neutrophils produce MCP-1 and respond to MCP-1. However this direct role of MCP-1 has a
minimal effect on neutrophil recruitment.
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Figure 3.8. A. Cellular recruitment into the alveoli after i.t. treatment with rMCP1(10g and 50g) alone. After 12 h, BALF was processed for cellular count. (n=5-6
mice/group; p<0.005, data are a representation of 3 individual experiments). MPO,
myeloperoxidase. B. CCR2 expression in neutrophils. Flow cytometric analysis of BALF and
blood from WT mice at 24h after i.t. E. coli (1X106 CFU/mouse) infection. This is a
representative data of 3 independent experiments with similar results. D. Picture
demonstrating the number of PMNs in the lower chamber of transwell plate after incubation
with chemoattractants rMCP-1 and KC. The figure is representative of 20 random fields from
3 separate experiments. E. Chemotaxis of neutrophils towards MCP-1. PMN numbers in the
lower chamber of transwell after 3 h of incubation with rMCP-1 and KC. Data shown here is
a representation of 3 individual experiments where n=3-5 and p<0.05. F. Bone marrow
neutrophils produce MCP-1 at 2 h after E. coli infection. (n=4-6 mice/group from 3 separate
experiments).

Macrophages Obtained from MCP-1-/- Mice Show Reduced NF-B and MAPK
Activation. In order to confirm the activation of NF-B and MAPKs in the lungs, we used
alveolar macrophages obtained from WT and MCP-1-/- mice. Macrophages were infected
with E. coli and samples were collected at 2 and 6 h for Western blotting. We found reduced
NF-B and MAPKs activation in MCP-1-/- mice following infection (Fig: 3.9A-B).
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Figure 3.9. A-B. Activation of
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macrophages obtained from
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infection
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E.
coli.
Representative Western blots from
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B. Relative densities normalized
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GAPDH
are
representatives of 3 independent
experiments (n=4-5/mice/group; *,
p<0.05).
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Discussion

In the present investigation, we sought to determine the importance of MCP-1 in an
experimental model of bacterial pneumonia and in the human system. We found MCP-1
expression is substantially increased following intratracheal E. coli infection and MCP-1 is
important for bacterial clearance during E. coli infection of the lungs. In addition we also
show that MCP-1 is being produced by both myeloid and non-myeloid cells following E. coli
infection. Our study demonstrate that MCP-1 directly (via chemotaxis) and indirectly (via
modulation of KC and MIP-2) contributes to neutrophil recruitment during E. coli pneumonia
(Figure 3.10).

In previous studies using mouse models, MCP-1 has been shown to play a protective
role against pulmonary pathogens, including Streptococcus pneumoniae (13, 45, 46),
Pseudomonas aeruginosa (2, 35) and Cryptococcus neoformans (20). In studies of
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pneumococcal and Pseudomonas pneumonia, inhibition of MCP-1 by antibodies reduced
monocyte but not neutrophil recruitment (2, 13). MCP-1 has also been shown to be associated
with the influx of T lymphocytes to inflammatory sites (10). Our results demonstrate that
rMCP-1 in the presence or absence of E. coli infection causes neutrophil and macrophage
influx into the lungs. Our findings also demonstrate attenuated macrophage and neutrophil in
the lungs of the gene deficient mice after E. coli challenge. These findings are consistent with
an earlier report demonstrating that blocking MCP-1/CCR2 reduced neutrophil accumulation
in the lung following i.t. treatment with MCP-1/LPS(30) or Cryptococcus neoformans
infection (20). The Maus group (29) showed that administering MCP-1 alone didn’t bring
neutrophils to the lungs but MCP-1 plus LPS synergistically causes neutrophil trafficking to
the lungs of BALB/c mice. However, we found rMCP-1 alone causes neutrophil influx into
the lungs of the WT (C57BL/6) mice compared to the PBS controls. Further, we show that
neutrophils from blood, BALF and bonemarrow express CCR2 and which is enhanced upon
infection, bone marrow neutrophils migrate towards rMCP-1 suggesting that MCP-1 can act
as a direct neutrophil chemoattractant. In addition, the Beck-schimmer group (4) has shown
that LPS induced neutrophil recruitment depends on MCP-1 production. A study by Lida et
al. has shown that murine bone marrow neutrophils express functional CCR2 and migrate
towards MCP-1 (21). Additional studies have shown that normal neutrophils are not
responsive to MCP-1, although neutrophils become responsive to MCP-1 when the animal
become septic after cecal ligation and puncture (CLP) (40). A study by the Johnston group
(23) shows that chronic inflammation induces neutrophils to express CCR2 in order to cause
migration towards MCP-1. Furthermore, in other acute inflammatory models such as acute
pancreatitis and colitis MCP-1 has been shown to be critical for neutrophil recruitment and
blocking MCP-1 with bindarit reduced neutrophil numbers and inflammation (5, 6). These

62

observations strongly suggest that neutrophils are directly responsive to MCP-1 and our
findings show the importance of MCP-1 in neutrophil recruitment to the lungs.
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Figure 3.10. Proposed model of MCP-1 mediated
neutrophil recruitment to the lung during E. coli
infection. E. coli induces MCP-1 through MD-2
signaling pathway which involves Toll-like receptors.
MCP-1 in turn regulate neutrophil recruitment directly
via chemotaxis and indirectly though KC, MIP-2 as
well as the cytokine TNF-

Neutrophil
recruitment
Bacterial clearance

Our findings show that MCP-1 can indirectly regulate neutrophil influx by regulating
the expression of CXC chemokines. We observed reduced expression of cytokines (TNF-
and IL-6) and chemokines (KC and MIP-2) in MCP-1-/- mice compared to the controls after
E. coli infection and when MCP-1-/- mice were reconstituted with rMCP-1 the cytokine and
chemokine levels returned to the level of WT mice during E. coli infection. In line with this
finding a previous study in a rat gastric ulcer model suggests that MCP-1 can regulate the
expression of CXC chemokines and cause neutrophil recruitment(44). Moreover, Gouwy et
al. showed that extracellular signal by CCL2 significantly enhances CXCL-8 expression on
monocyte (15) suggesting that CCL2/CCR2 signaling can regulate the expression of CXC
chemokines. Further, the Herbold group (17) demonstrated that CXCR-2 signaling can lead
to macrophage recruitment during S. pneumoniae infection. These observations suggest that
there is an interplay between CC and CXC chemokines.
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LTB4 is a known neutrophil chemotactic lipid which can be generated by leukocytes
from arachidonic acid (19) and act via G-protein coupled receptors to cause leukocyte
accumulation, microbial killing and generation of pro-inflammatory mediators (26, 36). In an
earlier study using a cecal ligation and puncture (CLP) model, it has been shown that MCP-1
inhibition attenuated neutrophil influx via the down-regulation of LTB4 production (37).
From our results, it is also possible that the attenuated level of LTB4 was the result of the
reduced number of migrating neutrophils in MCP-1-/- mice. However, the attenuation was
significant at 6 h and not significant at 24 h post- E. coli infection. Since LTB4 itself can lead
to generation of other proinflammatory mediators and neutrophil chamoattractants (36),
reduction of the neutrophil chemoattractant lipid, LTB4, at 6 h would have lead to reduced
neutrophil influx at 24 h.

We observed reduced NF-B activation and activation of MAPKs in MCP-1 gene
deficient mice during E .coli infection. These observations suggest that MCP-1/CCR2 axis
regulates NF-B and MAPKs activation. Consistent with this finding, Viedt et al. showed
that MCP-1 can activate NF-B and MAPKs during renal inflammation(43). It is also
possible that other transcription factors, such as AP-1 and STAT-1 can be activated via
MAPKs by MCP-1 (14). Therefore, our results suggest that MCP-1/CCR2 signaling regulates
the expression of CXC chemokines (MIP-2 and KC) through NF-B and MAPKs. Regulation
of CXC chemokines and cytokines through NF-B and MAPKs by MCP-1 can be attributed
to macrophage recruitment as MCP-1 is primarily a monocyte chemoattractant therefore we
used alveolar macrophages from wild-type and MCP-1-/- mice to determine whether reduced
MCP-1 levels have any effect on activation of NF-B and MAPKs. We observed reduced
activation of transcription factor NF-B and MAPKs in the MCP-1-/- macrophages following
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E. coli infection. These findings confirm our in vivo data that in addition to macrophage
recruitment, MCP-1 could regulate NF-B and MAPK mediated macrophage activation.

Recruitment of leukocytes to the tissues involves up regulation of cell adhesion molecules(3).
In this regard, we found that VCAM-1 up regulation was dependent on MCP-1. This was
most pronounced at 24 h following E. coli infection when neutrophil influx in the lungs was
at peak. These observations suggest that VCAM-1 plays an important role in the
transmigration of both neutrophils and monocytes to the lungs during E. coli infection in a
MCP-1 dependent manner.

Previous studies have shown that MCP-1 is important for bacterial killing by macrophages
(35, 38). Furthermore, studies have shown that neutrophils play an important role in the
bacterial clearance during gram-negative bacterial infections (27, 47). Since we found
reduced neutrophil numbers and enhanced bacterial burden in MCP-1-/- mice following E.
coli infection, we depleted neutrophils in wild-type mice to determine the role of neutrophils
in augmenting bacterial clearance. Our results show that neutrophils are indeed important for
the clearance of E. coli in the lungs. Further experiments involving MCP-1 restoration in
MCP-1

-/-

mice demonstrate the importance of MCP-1 in bacterial clearance from the lungs.

Although there is a higher bacterial burden in the lungs of MCP-1−/− mice, both WT and
MCP-1−/− mice cleared infection after 24 h, and no mortality was observed after infection.

Overall, our study reveals a novel role for MCP-1, that MCP-1 directly as well as
indirectly is involved in neutrophil recruitment during E. coli pneumonia. Herein we show
evidence of MCP-1 being a direct neutrophil chemoattractant and indirectly it regulates the
expression of other chemokines (KC and MIP-2) and cytokines (TNF-and IL-6) to cause
neutrophil trafficking (Fig. 2.10). Identification of these novel molecular MCP-1 mediated
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mechanisms triggered by E. coli could be useful to design better therapeutic strategies during
infections by gram-negative bacterial pathogens.
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Chapter 4
Intrapulmonary G-CSF Reverses Neutrophil Recruitment to the Lung and
Neutrophil
-/Release to Blood in Klebsiella pneumoniae Infection in MCP-1 Mice
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Introduction
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are caused by
multiple factors, including aspiration, sepsis, hyperoxia and bacterial pneumonia (1).
Klebsiella pneumoniae (Kp) is one of the most frequently isolated Gram-negative pathogens
associated with nosocomial pneumonia (2, 3). In light of the emergence of carbapenem
resistant Kp along with increasing numbers of immunocompromised individuals, an
understanding of innate immune mechanisms of the lung and how they may be augmented is
critical (4).

Recruitment of neutrophils to the lungs is a multistep process involving
granulopoiesis, neutrophil release, expression of neutrophil chemoattractants, cellular
adhesion molecules and other proinflammatory mediators and eventual transmigration of
neutrophils into the alveolar spaces (5-7). In this regard, neutrophils play a key role in
mucosal defense against intrapulmonary Kp infection since neutrophil depletion by anti-Gr-1
Ab makes the host more susceptible to infection (8, 9). Production of chemokines in the lung
is the first critical step in neutrophil recruitment (5-7) .

Monocyte chemoattractant protein 1 (MCP-1/chemokine [C-C motif] ligand 2
[CCL2]) is a potent monocyte/macrophage and T cell chemoattractant against bacteria
infecting the lung (10-13). MCP-1 is produced by a variety of cells, including endothelial
cells (14), epithelial cells , fibroblasts(15), and myeloid cells (monocytes/macrophages) (16).
It binds to the G protein-coupled transmembrane receptor chemokine receptor 2 (CCR2) to
induce

downstream

signaling

events

(17).

The

important

role

of

MCP-1

in

monocyte/macrophage-mediated host defense against bacterial infection has been
documented by previous studies. MCP-1 over expression augments bacterial clearance during
Streptococcus pneumoniae infection (18). Using gene-deficient (MCP-1−/−) mice, Winter et
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al. (19) have reported that MCP-1-induced macrophage migration is required to prevent
bacterial dissemination following intrapulmonary Streptococcus pneumoniae infection. In a
mouse model of Pseudomonas aeruginosa infection, MCP-1 promoted resolution of
inflammation and repair of the lung by augmenting uptake of neutrophils by alveolar
macrophages (20). In addition, CCR2 -/- mice exhibit reduced macrophage influx-mediated
bacterial clearance from the lungs and distal organs in response to intravenous challenge with
Listeria monocytogenes (21). MCP-1 is also shown to be essential for the survival of mice
and macrophage-mediated bacterial killing during P. aeruginosa and Salmonella enterica
serotype Typhimurium infections (10). We recently demonstrated that neutrophils expressing
CCR-2 and MCP-1 can recruit neutrophils directly as well as indirectly by regulating the
expression of CXC neutrophil chemokines during E. coli infection (5). Our study was limited
in that E. coli neither disseminates nor induces death in mice following intrapulmonary
infection and the role of bone marrow and/or resident cells in host immunity is unclear; and
the mechanisms underlying neutrophil accumulation in the lungs against E. coli have not
been explored.

In this study, we demonstrate the role of MCP-1 in Kp lung infection because Kp is
an important Gram-negative pulmonary pathogen that also extensively disseminates to
extrapulmonary organs with a small intrapulmonary inoculum. Using MCP-1-/- mice, we
found that MCP-1 is vital for bacterial clearance from the lungs following i.t. Kp infection
and ultimately survival of the mice. In addition, MCP-1 regulates neutrophil recruitment to
the lungs directly through CCR2 upregulation and indirectly via regulating CXC neutrophil
chemokines in the lungs. To test the hypothesis that G-CSF protein is necessary and
sufficient to restore MCP-1 deficiency, we administered granulocyte colony stimulating
factor (G-CSF) by intratracheal instillation into the lungs of Kp-infected mice. Impairment in
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survival, bacterial clearance and neutrophil mobilization to the circulation in MCP-1-/- mice
were reversed by administration of G-CSF.
Materials and Methods

Mice: Eight to 10-wk-old female mice genetically deficient in MCP-1 (22) were used while
age- and gender-matched C57Bl/6 mice were used as controls. All animal studies were
approved by the Louisiana State University Animal Care and Use Committee. The mice
ranged from 19 to 25 g in weight.

Murine Model of Infection: Bacteria were prepared for mouse inoculation, as described in
previous studies (9, 23). Kp serotype 2 (American Type Culture Collection (ATCC) 43816)
was grown in trypticase soy broth (TSB) at 37°C overnight under constant agitation. Bacteria
were harvested, washed, and resuspended in sterile 0.9% saline at a concentration of 20 X106
CFU/ml. Mouse strains were anesthetized with i.p. ketamine/xylazine (250 mg/kg), followed
by intratracheal (i.t.) inoculation of 50 µl of bacteria (10 3 CFU/mouse) where as control mice
were i.t. inoculated with 50 µl of saline. The initial mouse inoculums were confirmed by
plating serial 10-fold dilutions on MacConkey and tryptic soy agar (TSA) plates. For
enumerating bacterial CFU in the lung and spleen, whole lungs and spleens were
homogenized in 2 ml sterile saline for 30 s, and 20 µl of the resulting homogenates were
plated by serial 10-fold dilutions on MacConkey and TSA plates. In a similar manner, spleens
were homogenized for 15 s for bacterial culture. Bacterial colonies were counted after
incubation overnight at 37oC.

Bronchoalveolar Lavage Fluid (BALF) Collection: BALF was collected and total and
differential

cell

counts and cytokine/chemokine

concentrations were determined.

Approximately 3 ml of lavage fluid was retrieved per mouse. Total leukocytes in BALF were
determined using a hemocytometer. Cytospin samples were subsequently prepared from
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BALF cells and stained with Diff-Quick (Fisher). Differential cell counts were determined by
direct counting of stained slides. For examination of cytokines/chemokines, the remainder (2
ml) of the undiluted cell-free BALF was passed via a 0.22-µm filter and used immediately or
stored at -80oC (5, 24-26).

Lung Pathology: The lungs were perfused from the right ventricle of heart with 10 ml
isotonic saline at 24 h post infections described earlier (23). Lungs were then removed and
fixed in 4% phosphate-buffered formalin. Fixed tissue samples were processed and stained
with hematoxylin and eosin (H&E). Semiquantative histopathology was performed in blinded
fashion by a Veterinary Pathologist according to the following scoring scale: 0, No
inflammatory cells (macrophages or neutrophils) present in section; 1, <5% of section is
infiltrated by inflammatory cells; 2, 5–10% of section is infiltrated by inflammatory cells; and
3, >10% of section is infiltrated by inflammatory cells.

Measurement of Cytokines and Chemokines: We used BALF and lungs that were obtained
from animals after Kp infection or saline instillation. ELISA kits for TNF-α, IL-6 and MCP-1
were obtained from eBiosciences, PA whereas kits for KC and MIP-2 were obtained from
R&D systems, MN. The minimum detection limit is 8 pg/ml cytokine protein (5, 26).

Immunoblotting: The lungs were collected at the designated time points and used for
Immunoblotting as described in our previous publications (23, 24). The primary Abs to
phospho-NF-B/p65(ser 536), NF-B/p65,, phospho-IBser 32), phospho-p44/42 MAPK
(Erk1/2)

(Thr202/Tyr204),

phospho-p38

MAPK

(Thr180/Tyr182),

phospho-JNK

(Thr183/Tyr185) were added at a 1:1,000 dilution. The primary Abs to total p38, and
GAPDH (Santa Cruz Biotechnology, CA) were added at 1:5,000 dilution. Immunostaining
was performed using appropriate secondary Ab at a dilution of 1:2,000 and developed with
ECL plus Western blot detection system (Amersham Pharmacia Biotech, Piscataway, NJ). To
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demonstrate equal protein loading on gels, the blots were stripped and reprobed with Ab
specific for total p38, pan Cadherin or GAPDH.

MPO Activity in Neutrophils. MPO release by the neutrophils was measured as previously
described in our publications (27).
Bone Marrow Chimeras. Donor and recipient mice (6-8 wk old) were used to generate
chimeras, as described in our previous publications (5, 28). Recipient mice were γ irradiated
from a cesium source in two 525-rad doses 3 hours apart. Bone marrow cells (8 × 106/mouse)
were injected into the irradiated recipients via the tail vein. Chimeric mice were maintained
on 0.2% neomycin sulfate for the first 3 weeks. The reconstituted mice were used 8 weeks
post-transplantation. We found that greater than 86% of blood leukocytes were derived from
donor mice at the time the mice were used for experiments. Irradiated mice that were not
transplanted with donor cells died between days 20 and 23 post-transplantation.
Administration of either rMCP-1 or rG-CSF: MCP-1 -/- mice were treated i.t. with rMCP1 (5 μg/animal) or rG-CSF (1 μg/mouse) 30 mins after Kp infection (103 CFUs/50μl/animal)
and the control mice were treated with an equal volume of PBS with BSA. At 24 h postinfection, BALF was collected and processed for cellular enumeration and the determination
of CFUs. For survival experiments mice were observed for 14 days post treatment.
Absolute Blood Neutrophil Count: Total leukocyte count was determined in 100 l of
blood. Differential leukocyte count was determined in cytospin slides made from each
sample after staining with diff-quik reagents. Total leukocyte count was calculated based on
neutrophil percentage and total blood volume (weight X 0.06%= total blood volume).
Total

leukocyte

count

X

Neutrophil

percentage

absolute blood neutrophil count.
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X

total

blood

volume

=

Flow Cytometry: A total of 50 µl of whole blood or BALF of WT and MCP-1-/- mice treated
with saline or Kp was aliquoted into flow cytometry tubes and Fc blocked. A total of 10 µl of
mouse conjugated anti-mouse Gr-1, CCR2, and CXCR-2 (R&D, Minneapolis, MN)
antibodies were added to appropriate tubes. Samples were vortexed and incubated for 30 min
at room temperature in dark. Cells were washed by adding 2 ml of 1X PBS and centrifuged at
1000 rpm (200 x g)/8 min. RBCs were lysed using 2 ml of NH4Cl lysing buffer to each
sample tube, mixed well and incubated at room temperature for 10 min. Samples were
centrifuged immediately at 1000 rpm (200 x g)/8 min and the supernatant was removed. Cells
washed twice with PBS. Cells were fixed by adding 200 µl of cold 1% formaldehyde-PBS
and stored at 2-6 oC for FACS analysis (5, 29).

Statistics: Data are expressed as mean + SE. The intensity of immunoreactive bands was
determined using a Gel Digitizing Software (UN-SCAN-IT gelTM) from Silk Scientific, Inc,
Utah, US. Data were analyzed by one way ANOVA followed by Bonferroni’s post hoc
analysis for multiple comparisons. All statistical calculations were performed using InStat
software and GraphPad Prizm 4.0. Differences were considered statistically significant at
*P<0.05 when compared with control. Survival curves were compared by Wilcoxon signedRank test.

Results

Effect of MCP-1 Deletion on Survival and Bacterial Clearance. First we assessed whether
MCP-1 is protective in mice against i.t. Kp infection of the lungs. We infected MCP-1-/- mice
and WT (C57Bl/6) controls with 103 Kp CFUs and monitored for up to 10 days. We observed
MCP-1-/- mice were more susceptible to Kp infection compared to the wild-type controls. All
knockout mice died within 6 days post infection while 85% of WT mice survived (Fig. 4.1A).
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In order to determine whether this impaired survival was due to a defect in bacterial clearance
from the lung and/or bacterial dissemination, bacterial loads in the lung and extrapulmonary
organs, including blood, spleen and liver were determined. Mice were infected with i.t. Kp
and sacrificed at 24 and 36 h post-infection and the lungs, blood, spleens and livers were
collected to quantitate bacterial CFUs. In MCP-1-/- mice, higher bacterial loads were found in
the lungs accompanied by enhanced dissemination to spleen and liver and blood (Figs. 4.1BE). Thus, MCP-1 clearly plays a role in the survival and bacterial clearance of K. pneumoniae
infection.

Effect of MCP-1 Deletion on Neutrophil Recruitment. MCP-1 is important for neutrophil
and macrophage recruitment to the lungs in response to i.t. E. coli infection (5). The
antibacterial defenses of the lung to Kp include the recruitment of the PMN from the
systemic vasculature (5, 6, 30). Having determined that MCP-1 mediates survival and
bacterial clearance to Kp infection, we next examined the total leukocyte and PMN numbers
in BALF at 24 and 36 h post-infection. We found reduced neutrophil numbers, but
macrophage numbers were not significantly reduced at 24 and 36 h post infection in the
knockout mice (Figs. 4.1F-H). Lung myeloperoxidase (MPO) activity showed significant
differences in neutrophil accumulation in lung parenchyma between WT and MCP-1-/- mice
at 24 and 48 h post-Kp infection (Fig. 4.1I). Histopathology of MCP-1-/- lungs showed a
reduction in neutrophil numbers in lung parenchyma (Fig. 4.1J) whereas higher numbers of
bacteria were found in these lungs 36 h after Kp infection (Fig. 4.1J). In marked contrast,
photomicrographs of lung sections in MCP-1-/- and WT mice challenged with saline showed
no significant changes (Fig. 4.1J).
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Figure 4.1: Importance of MCP-1 in host defense against pulmonary Kp infection: A.
Reduced survival in MCP-1-/- mice following i.t. Kp infection. MCP-1-/- and WT (C57Bl/6)
mice were i.t. inoculated with 103/mouse of Kp, and survival was monitored up to 10 days.
n=14 mice in each group. *, P<0.05 determined by Wilcoxon Rank Sign Test. B-E. Impaired
bacterial clearance in the in MCP-1-/- mice after i.t. Kp infection (103/mouse). Bacterial CFUs
in mice were determined in lungs, spleens, livers and blood of MCP-1-/- and WT mice after
Kp infection. Data represent mean + SE of 4-6 mice at each time point. *, Significant
differences between MCP-1-/- and WT mice (P<0.05). F-H. Total leukocyte, neutrophil and
macrophage numbers in the lungs of MCP-1-/- mice after Kp inoculation. Both MCP-1-/- and
WT animals underwent BAL fluid and lung collection after challenge with Kp. I. MPO
activity in homogenized (unlavaged) whole lungs of WT and MCP-1-/- mice infected with K.
pneumoniae (103 CFU/mouse) for 24 and 36 h. Data are presented as means + SEM. n=6-8
mice/group. (* indicates p<0.05 compared with MCP-1-/- mice). J. Lung histology in MCP-1/mice following Kp inoculation. Lung sections were made 36 h after bacterial or saline
challenge and stained with H&E. Score for leukocyte numbers in the lesion and bacterial
numbers were calculated as described in Materials and Methods. These are representative
sections of 4 mice in each condition with comparable results (Magnification x200).

Determination of Proinflammatory Cytokines/Chemokines Following i.t Kp Challange.
Neutrophil recruitment is a sequentially regulated process in which cytokine/chemokine
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production plays a critical role. Since neutrophil recruitment to the lungs was reduced in
MCP-1-/- mice following Kp infection, we then examined the MCP-1 dependence of
cytokine/chemokine concentrations in the BALF induced by Kp infection. We found a
universal reduction in cytokines (TNF-α and IL-6) and neutrophil chemoattractants (KC and
MIP-2) in MCP-1-/- mice at 36 h after i.t. Kp inoculation (Figs.4.2A-D). These data provide
evidence impaired expression of cytokines and neutrophil chemoattractants in the absence of
MCP-1 during Kp infection.

Assessment of Activation of NF-B and MAPKs Following Kp Administration.
Expression of inflammatory genes is regulated by NF-B and MAPKs (6, 31, 32). Having
found reduced expression of cytokines and chemokines in BALF following Kp infection, we
then investigated the activation of NF-B and MAPKs in the lungs following Kp infection.
As demonstrated in Figs. 4.2E-F, the data show reduced NF-B activation in MCP-1-/- mice
after 36 h of Kp challenge. In addition, MCP-1-/- mice infected with Kp exhibit reduced
activation of p38, p42/44 MAPK and JNK at 24 h and 36 h of infection (Figs. 4.2G-H). These
data demonstrate that MCP-1-/- mice have a defect in NF-B and MAPK activation.
Administration of rMCP-1 to MCP-1-/- Mice after Kp Infection Restores Survival,
Bacterial Clearance and Neutrophil Accumulation Following i.t. Challenge with Kp. To
validate the possibility that impaired survival, bacterial clearance and neutrophil accumulation
in the lungs of MCP-1-/- mice is indeed due to a genetic defect, we treated the MCP-1-/- mice i.t.
with recombinant MCP-1 (rMCP-1) 1 h after i.t. Kp infection and examined survival, CFUs in
lungs and distal organs as well as neutrophil influx. The effect of MCP-1 post-treatment on
survival after i.t. challenge with Kp in MCP-1-/- is shown in figure 4.3A. MCP-1 markedly
enhanced survival in MCP-1-/- mice treated with rMCP-1 (Fig. 4.3A). Moreover, post-treatment
with MCP-1 significantly attenuated bacterial CFUs in lungs and spleen in MCP-1-/- mice (Fig.
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4.3B-C). Furthermore, rMCP-1 post-Kp treatment augmented neutrophil accumulation in MCP1-/- mice (Figures 4.3D-E).
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Figure 4.2: Impairment of airspace cytokine responses in MCP-1-/- mice after infection
with Kp. A-D. Cytokine (TNFIL-6) and chemokine (MIP-2 and KC) concentrations in
BAL fluid were measured by sandwich ELISA after infection with Kp. Protein
concentrations (pg/ml) are expressed as mean + SE and 4-6 animals were used at each time
point. Significant differences between MCP-1-/- and WT mice are indicated by asterisks
(p<0.05). E-F. Activation of NF-B in the lung following infection with Kp. Lung
homogenates from MCP-1-/- mice and their controls were prepared at 24 and 36 h after
infection with Kp. NF-B expression and phosphorylation of NF-B and IBα were
determined using western blots of lung homogenates. The blots are representative of 3
independent experiments with similar results. F. Relative densities normalized against
GAPDH are representatives of 3 independent experiments. G. Activation of MAPKs in the
lung following Kp infection. Total proteins in the lung were isolated from MCP-1-/- and
control mice at 24 and 36 h after infection with Kp, resolved on an SDS-PAGE and the
membrane was blotted with the Abs against activated/phosphorylated form of MAPKs as
described in Materials and Methods. This is a representative of 3 separate experiments with
similar results. H. Densitometric analysis of MAPK activation was performed from 3 separate
blots. *denotes the difference between MCP-1-/- mice and their WT controls (p<0.05).
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Neutrophil Recruitment in Response to Kp Iinfection Requires MCP-1 by BM-Derived
and Resident Lung Cells. Since host response to bacteria in the lung is derived from both
resident alveolar cells and/or recruited bone marrow cells, we examined which cell-derived
MCP-1 was essential in promoting neutrophil recruitment, thus host innate immunity. To
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address this question, we used irradiation (500 rad 3 hrs apart) to eliminate all bone marrow
cells in the recipient mice. These lethally irradiated recipient WT and MCP-1-/- mice were
reconstituted with bone marrow from donor WT or MCP-1-/- mice to generate four groups of
chimers: 1) WT mice reconstituted with WT marrow (WT→WT); 2) WT mice reconstituted
with MCP-1-/-marrow (MCP-1–/–→WT); 3) MCP-1-/- mice reconstituted with WT marrow
(WT→MCP1–/–); and 4) MCP-1-/- mice reconstituted with MCP1–/– marrow (MCP-1–/–→
MCP1–/–). At 8 wk post-transplantation, these bone marrow chimeric mice were i.t.
inoculated with Kp and inflammatory parameters in the lungs were examined. At 48 h postKp infection, neutrophil recruitment to the lungs in response to K. pneumoniae infection was
increased in irradiated WT−/− reconstituted with WT bone marrow (Fig. 4.4B) whereas Kpinduced neutrophil influx was attenuated in irradiated MCP-1−/− reconstituted with MCP-1−/−
bone marrow (Fig. 4.4B). Irradiated MCP-1−/− mice reconstituted with MCP-1+/+ bone
marrow and irradiated MCP-1+/+ mice reconstituted with MCP-1-/- bone marrow did show a
similar degree of neutrophil influx in response to K. pneumoniae infection (Fig. 4.4B) Not
surprisingly, neutrophil recruitment to the lung was not observed in reconstituted mice after
saline challenge in all 4 chimera groups (data not shown). These observations suggest that
MCP-1 by both resident and bone marrow cells is required for neutrophil-mediated host
immunity against Kp.
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Kp Infection Augments CCR2 Expression on Blood Neutrophils. As lung macrophage
recruitment was not altered during Kp-induced inflammation, we hypothesized that the
accumulation of neutrophils in lung inflammation may reflect increased chemotaxis, in addition
to the reduced chemokine concentrations. Specifically, we studied whether the increased
accumulation of neutrophils in the lungs required the expression of CCR2 selectively on this
cell type. To perform this, we infected MCP-1-/- and WT mice i.t. with 103 CFUs of Kp and
collected blood at 24 and 36 h post-infection and then stained with CCR2 antibody and Ly6G
antibody for flow cytometry. We found that the level of CCR2 expression on neutrophil
populations was increased with time following Kp infection (Fig. 4.5A-B).
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Figure 4.5: CCR2 expression in blood neutrophils of WT and MCP-1-/- mice after Kp
infection. Flow cytometric analysis of blood from WT mice at 24 and 36 h after i.t. Kp (1X103
CFU/mouse) infection using tagged antibodies against CCR2 and Gr1(Ly6G)(A-B). This is
representative of 3 independent experiments with comparable results. C. Neutrophil numbers in
blood of both WT and MCP-1-/- mice following Kp infection. Neutrophils were gated and the
percentage of Gr-1/Ly6G positive cells were determined. G-CSF concentrations in BALF and
in blood of WT and MCP-1-/- mice following i.t. Kp infection (E-F) determined by using
sandwich ELISA. n=4-8 and *p<0.05.

Kp-Induced MCP-1 Modulates Blood Neutrophil Numbers. Neutrophil recruitment to the
site of infection is a multistep event which involves neutrophil release from bone marrow (33).
We found more bacterial dissemination (Fig. 4.1A-D) in MCP-1-/- mice upon i.t. Kp infection
along with reduced neutrophil influx to the site of infection (Figs. 4.1F-I). We therefore asked
whether it is the defect in recruitment to the lung or release of neutrophils to the blood from
marrow. In order to explore these possibilities, we infected both WT and MCP-1-/- mice i.t. with
Kp and collected blood at 24 and 36 h post infection and determined the blood neutrophil
numbers. We found neutrophil numbers in both WT and MCP-1-/- mice were significantly
increased at 24 and 36 h post Kp infection but the magnitude was less in MCP-1-/- mice (Fig.
4.5C-D).
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MCP-1 Regulates the Expression of G-CSF. G-CSF is a known cytokine implicated in
granulopoiesis and neutrophil mobilization (34, 35). Since we found reduced neutrophil
numbers in the circulation of MCP-1-/- mice, we studied whether MCP-1 affects the expression
of G-CSF in blood following Kp exposure using ELISA. We found reduced G-CSF
concentrations in MCP-1-/- mice in serum and as well as BALF as compared to their littermates
(Fig. 4.5E-F).
Instillation of MCP-1 in MCP-1-/- Mice Restores Blood Neutrophil Numbers and G-CSF
Concentrations. After identifying a pronounced requirement of MCP-1 for G-CSF
production and neutrophil release to the blood, we evaluated whether MCP-1 is necessary and
sufficient to induce neutrophil release to the blood. Next we reconstituted MCP-1-/- mice with
rMCP-1 and found increased blood neutrophil numbers in blood and BALF, even in the
absence of infection in a concentration-dependent manner (Figs. 4.6A-C). We also observed a
substantial increase in G-CSF expression in blood and BALF following rMCP-1
administration in a concentration-dependent manner (Fig. 4.6D). In addition, we performed
similar experiments in the presence of Kp infection. Kp infected mice were administered with
rMCP-1 at 1 h post-infection. We found that rMCP-1 rescues blood neutrophil counts (Fig.
4.7A-B), G-CSF concentrations in blood (Fig. 4.7C) and G-CSF concentrations in
blood/serum (Fig. 4.7C). These observations suggest that MCP-1 regulates neutrophil
numbers in the blood through G-CSF production in the absence or presence of Kp infection.
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Figure 4.6: Increased neutrophil numbers in BALF and blood in a dose dependent
manner after i.t. treatment with rMCP-1 (A-C). A-C. Blood neutrophil numbers were
determined 24 h after i.t. treatment with rMCP-1 in two different doses (5 and 10g/mouse)
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rG-CSF Treatment Reverses the Host Defense Defect in the MCP-1-/- Mice in Response
to Kp Challenge. Since we observed reduced neutrophil numbers in the blood associated
with reduced G-CSF concentrations, we wanted to determine whether G-CSF treatment can
improve host defense in MCP-1-/- mice following Kp infection. We treated MCP-1-/- mice i.t.
with 1 g G-CSF 1 h post Kp infection and observed that the survival of the knockout mice
was significantly improved (Fig. 4.8A). In a similar manner, we found reduced bacterial
burden in the lungs and dissemination to the extrapulmonary organs, including spleen in mice
i.t. treated with 1 g G-CSF 1 h post-Kp infection (Figs. 4.8B-C). Furthermore, neutrophil
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accumulation in the lungs was enhanced in mice following G-CSF administration (Figs.
4.8D-E).
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Discussion

We recently reported that MCP-1 can recruit neutrophils to the lung during E. coli infection
directly through chemotaxis and indirectly through the production of neutrophil
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chemoattractants, including KC and MIP-2. Nevertheless, several limitations noted in this
model: 1) E. coli is rapidly cleared from the lungs; 2) E. coli does not induce bacterial
dissemination. Because of these limitations, we used Kp in the current investigation to
examine host immunity in the lungs and extrapulmonary organs since this bacterium
disseminates following intrapulmonary inoculation and thus, induces both local and systemic
immune responses.
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Antimicrobial function of phagocytes is contingent on the ability of these phagocytes
to leave the bloodstream and enter the site of infection (5, 6). Numerous studies show that
MCP-1 is a potent monocyte/macrophage chemoattractant: In mouse of pneumococcal and
Pseudomonas pneumonia, blocking MCP-1 reduced monocyte but not neutrophil recruitment
(20, 36). In subsequent studies, MCP-1 has been shown to be associated with T lymphocyte
recruitment to the site of inflammation (11). We previously demonstrated that rMCP-1 in the
presence or absence of E. coli infection causes neutrophil and macrophage influx into the
lungs. In the current investigation, our findings show that MCP-1 induces neutrophil, but not
monocyte recruitment, to the lungs in response to i.t. Kp infection. These results are
consistent with earlier reports showing that blocking MCP-1/CCR2 attenuated neutrophil
influx in the lung following i.t treatment with MCP-1/LPS (37) or Cryptococcus neoformans
infection (38). In addition, the other study (39) implied that administering MCP-1 alone did
not cause neutrophil influx in the lungs but MCP-1 along with LPS synergistically induced
neutrophil migration to the lungs.

Recruitment of neutrophils by chemoattractants during the inflammatory process involves
chemotaxis (direct). Our results showed that neutrophils from blood and BALF express
CCR2, which was increased upon infection. In this context, we showed in our earlier report
that bone marrow neutrophils migrate towards rMCP-1 (5). Several other reports support
this. For instance, the Beck-schimmer group has indicated that LPS induced neutrophil influx
depends on MCP-1 production (40). Murine neutrophils express functional CCR2 and
migrate towards MCP-1 as demonstrated earlier (41). Further studies have shown that
unstimulated neutrophils are not responsive to MCP-1 despite the fact that neutrophils
become responsive to MCP-1 during sepsis in mice (42). In other acute inflammatory models
in mice, such as acute pancreatitis and colitis, MCP-1 has shown to be critical for neutrophil
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migration and blocking MCP-1 attenuated neutrophil counts and inflammation (43, 44). In
chronic inflammation, neutrophils upregulate CCR2 (45).

The other mechanism of neutrophil recruitment is that cytokines modulate the
expression of other neutrophil chemoattractants via indirect cascades. The present study
shows that MCP-1 regulates the expression of key neutrophil chemoattractants, including KC
and MIP-2. These findings are similar to our previous report which shows a) reduced
expression of chemokines (KC and MIP-2) in MCP-1-/- mice in response to E. coli infection
(5); and b) when MCP-1-/- mice were reconstituted with rMCP-1 the chemokines
concentrations returned to the level of WT mice during E. coli infection (5). These
observations also suggest that there is a complex interplay between CC and CXC
chemokines. This has been documented in earlier studies: 1) extracellular signal by CCL2
augments CXCL-8 expression on monocytes (46); and 2) CXCR-2 signaling can lead to
macrophage recruitment during S. pneumoniae infection (47).
NF-κB is one of the well-studied transcription factors that mediate the induction of
numerous inflammatory cytokines and chemokines (5, 32). Studies have demonstrated that
NF-κB activation is a critical event in the pathogenesis of bacterial pneumonia (5, 6, 48). We
observed decreased NF-B and MAPK activation in MCP-1 gene deficient mice during E.
coli infection. These observations suggest that the MCP-1/CCR2 axis regulates the activation
of NF-B and MAPKs. In this regard, it has been shown that MCP-1 can activate both NFB and MAPKs during renal inflammation (49). Our findings suggest that transcription
factors other than NF-B, such as AP-1 and STAT-1 can be activated via MAPKs in a MCP1-dependent manner. Together, our findings suggest that the MCP-1/CCR2 signaling axis
regulates the expression of CXC chemokines (MIP-2 and KC) through NF-B and MAPKs.
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The antibacterial defenses of the lung include the resident alveolar macrophages and
epithelium as well as the neutrophils and/or macrophages that migrate into the lung
parenchyma from the bloodstream (7, 33). Any defect in these functions will ultimately result
in infectious complications in the host. The relative contribution of hematopoietic/bone
marrow cells versus resident tissue cells in neutrophil recruitment to the lung from the
bloodstream has not been clear. However, the contribution of specific cell type is dependent
on the specific stimulus, because both of these cell types are exposed to PAMPs and danger
associated molecular patterns (DAMPs) during the insult. Bone marrow-derived cells in the
lung produce several neutrophil chemokines such as KC (50, 51) and MIP-2 (52, 53) whereas
resident cells, including alveolar epithelial type II cells, produce other neutrophil
chemoattractants, such as LIX (54). An interesting finding of this investigation was the
dependence of MCP-1 from both bone marrow cell and resident cells for neutrophil
accumulation in the lung in response to Kp infection. These findings are consistent with
previous reports demonstrating the role of bone marrow versus resident cells in lung
inflammation: a) MyD88 derived from bone marrow cells is more important for LPS-induced
expression of TNF-α and IL-12p40 (55), although both bone marrow and resident cellderived MyD88 are essential for LPS-induced neutrophil recruitment (56-58); b) MD-2
signaling cascades in both cell types is essential for neutrophilic inflammation, and the
expression of MIP-2, TNF-α, and IL-6 is mediated by both cell types in the lungs after LPS
administration (59); and c) the neutrophil chemokine KC produced by both bone marrow and
resident cells is important for bacterial clearance and neutrophil accumulation in the lung
upon Kp infection (60).

G-CSF is a cytokine produced by numerous cell types in the lungs, including
macrophages, fibroblasts, epithelial and endothelial cells (61-63). G-CSF has been shown to
be important for granulocyte production/maturation and neutrophil functions, including
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phagocytosis, chemotaxis and the production of reactive oxygen intermediates (64). We have
demonstrated that MCP-1 modulates the production of G-CSF in the blood and BALF in
response to Kp infection (Fig. 4C-F). Thus, rG-CSF reverses host defense defects in the
blood and BALF of MCP-1-/- mice (Fig. 6). These findings are consistent with earlier
observations that i.t. G-CSF instillation induced neutrophil infiltration to the lung (65, 66). GCSF in the lung could result in PMN migration through augmenting PMN adhesion to
endothelium (67, 68), and through enhancing PMN chemotaxis (68, 69). The movement of
PMNs from capillaries to the lung parenchyma requires transmigration of PMN across both
endothelial and epithelial cells. Our data suggest that intrapulmonary administration of GCSF following Kp infection can induce both transendothelial and transepithelial migration of
neutrophils. Based on our findings, it appears that the augmented neutrophil influx in the
lungs could have contributed to bacterial clearance from the lungs and blood (Fig. 6).

In conclusion, these studies suggest a role for MCP-1 in antibacterial defenses of the
lung via the production of G-CSF. To our knowledge, this is the first time that G-CSF was
used to overcome the MCP-1-dependent impairment in antibacterial defenses of the lung. In
humans, serum G-CSF concentrations increased during the acute phase of respiratory
infections, suggesting an essential physiologic role of G-CSF in determining the neutrophilmediated host defenses within the lung during pneumonia (70). The availability of
recombinant G-CSF affords the clinical use of G-CSF to augment innate host defense in
patients who either lack or have malfunctional MCP-1. However, the concentration of G-CSF
needs to be optimized to make sure that the dose of G-CSF does not induce PMN-induced
acute lung injury and possibly, ARDS. It has also been demonstrated that MCP-1
polymorphism is associated with increased susceptibility to Mycobacterium tuberculosis
infection (71, 72) and bacterial peritonitis (73).
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Conclusions
The respiratory system is the second largest system of the body that is directly exposed to the
environment. Therefore, it constitutively encounters numerous infectious agents and thus
bacterial lung infections are a leading burden of disease in the world and the most common
cause of acute lung injury. It is also a major cause of mortality in the US [1-3]. Tremendous
advances have been made in the treatment of pneumonia using broad spectrum antibiotics.
However, these strategies have resulted in the emergence of multi-drug resistant bacterial
strains[4, 5]. In addition to this, increasing populations of immunocompromised individuals
who are susceptible to pneumonia make the treatment of bacterial pneumonia increasingly
difficult. This necessitates novel therapeutic approaches to treat lower respiratory tract
bacterial infections. Immunotherapy to augment the host immune response can serve as an
adjunct to antibiotic treatment [3, 6]. Although both innate and adaptive immune responses
play important roles in the host defense, the innate immune response is the primary defense
against most acute infections. Innate defenses consist of structural defenses, antimicrobial
molecules, and phagocytosis by resident alveolar macrophages (AMs) and recruited
polymorphonuclear cells (PMNs)[7, 8]. According to studies with bacterial infections in
different models, neutrophils play a predominant role in containing the infection [9, 10]. Our
results also indicate that neutrophil depletion significantly impairs bacterial clearance during
E. coli infection in mice [11, 12].

Neutrophil recruitment is a very well orchestrated multi-step process. This involves a
complex network of cytokine/chemokine signaling. Therefore, cytokines/chemokines can be
used to boost neutrophil mediated host immune response. Many cytokines have pleiotropic
effects and can be involved in multiple facets of host defense[7, 8, 13]. MCP-1 has been
extensively studied for its role in monocyte recruitment and activation[14-16]. Different
studies indirectly indicated a role of MCP-1 with regard to neutrophil recruitment [17-19]. In
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chapter 2 we have shown that MCP-1 can act as a neutrophil chemoattractant directly and
indirectly through other cytokines (TNF- and IL-6) and chemokines (KC and MIP-2) during
E. coli infection of the lungs. We observed CCR2 expression on neutrophils which is
increased with infection both in-vitro and in-vivo. In an in-vitro transmigration assay we
observed neutrophils migrated towards rMCP-1. When we administered rMCP-1 to WT as
well as MCP-1-/- mice it caused neutrophil influx with or without infection. However, only 46% of neutrophils expressed CCR2. Therefore, the remarkable reduction in neutrophil
recruitment observed in the gene deficient mice could not be solely attributed to the direct
role of MCP-1 in neutrophil recruitment. With regard to the indirect role of MCP-1 by
controlling TNF- IL-6, KC and MIP-2, it was possible that reduced cytokines/chemokines
levels in the knock-out mice could be a result of lower numbers of recruited neutrophils in the
lungs because previous reports indicate that neutrophils also produce these cytokines and
chemokines during infection [20-22]. In addition, in this study, although we found higher
bacterial burden in the lungs of MCP-1 gene deficient mice, E. coli gets cleared off and
doesn’t disseminate to distal organs to cause mortality in bothe groups of mice after infection.

Because of these limitations, to delineate the mechanism of neutrophil recruitment by MCP-1
in acute bacterial infections we have chosen the pathogen Klebsiella pneumoniae in

Chapter 3. Interestingly we found not only neutrophil numbers in BALF but also blood
neutrophil numbers were low in MCP-1-/- mice after Klebsiella infection. We also found that
MCP-1 regulates G-CSF production with or without infection in mice. A single G-CSF dose
i.t. improved the neutrophil mediated host defense in MCP-1-/- mice after Klebsiella infection.
Our data indicate a direct role of MCP-1 in G-CSF regulation. However, the mechanism of
how MCP-1 regulates G-CSF is yet to be determined. In order to determine this, it is
important to determine the source of G-CSF in lungs upon Klebsiella infection. In previous
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studies, it has been shown that in addition to monocytes/macrophages[23], fibroblasts[23,
24], alveolar epithelial cells[24, 25] and endothelial cells[26] can also produce G-CSF upon
infection. Since we saw a remarkable increase in G-CSF levels in serum upon rMCP-1
treatment alone, it is possible that endothelial cells are the predominant source of G-CSF
production because they constitutively express the CCR2 receptor. However, in our model
this needs to be determined.

G-CSF is a member of the glycoprotein family that is essential for survival, proliferation
differentiation and release of hematopoietic cells and activation of neutrophils and
monocytes[23, 27]. Local administration of rG-CSF intratracheally has resulted in systemic
effects such as increasing blood neutrophil numbers, their microbicidal activity, and
extravasation. In animal experiments, including ours, it has been found that recombinant GCSF (filgrastim, pegfilgrastim or lenograstim) treatment has improved bacterial clearance
either by increasing neutrophil numbers or enhancing their function[23]. In a rabbit model,
rG-CSF improved survival during bacterial pneumonia/sepsis when combined with
antibiotics[3]. These findings are consistent with ours. In contrast, it has been shown that
prophylactic treatment with G-CSF worsened the outcome during Klebsiella pneumoniae
infection of the lungs in mice[27, 28]. Similar to this finding, during E. coli pneumonia,
administration of G-CSF impaired bacterial clearance and increased pulmonary injury and
mortality[27]. However, G-CSF has been FDA approved as a therapy in several neutropenic
conditions, such as patients with cancer receiving myelosuppressive chemotherapy, after
induction or consolidation chemotherapy for acute myelogenous chemotherapy, for myeloid
reconstitution after hematopoietic stem cell transplantation, for mobilization and collection of
peripheral blood stem cell for transplantation, and for severe chronic neutropenia[27, 29].
The most common side effect with such treatment is mild-to-moderate bone and/or
musculoskeletal pain that occurs in 20-30% patients and resolves with discontinuation of the
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treatment[27]. Therapeutic investigations in patients with community acquired pneumonia
receiving intravenous antibiotics and G-CSF for ten days have shown an increase in
circulating neutrophils, however, it did not affect time to resolution of morbidity, mortality or
length of hospitalization. The development of sepsis related organ failure or acute respiratory
distress syndrome was very much reduced[3, 27].

With regard to Klebsiella infection, studies have been done with other cytokines such as
TNF-, KC, MIP-2, IFN- and IL-12. Inhibition of endogenous TNF- has resulted in
increased mortality associated with higher bacterial burden in mice upon i.t. Kp infection[30].
When mice were treated either with TNF- agonists or TNF-expressing adenoviral vectors
prior or concomitant with infection, bacterial clearance and survival was much improved[6].
Although TNF-blocking decreased neutrophil numbers and administering TNF-increased
neutrophils following Kp infection, the beneficial effects of TNF-has not been defined
because TNF-itself is not chemotactic to neutrophils[30]. In addition, during Kp infection,
our lab and other labs have shown that neutrophil chemokines such as KC and MIP-2 are
essential for survival and bacterial clearance [6, 9, 31-33]. In our recent report, we have
shown that neutrophil defects in KC knock-out mice can be compensated by another
neutrophil chemokines, LtB4[34]. Another cytokine that has been shown to be critical for the
host defense against Kp infection is IFN-. During Kp infection, IFN- knock-out mice
showed significant mortality and when mice were administered with rIFN- host defense was
improved against Kp in alcohol intoxicated mice[30]. Similar to these findings, IL-12 has
also been shown to be essential for Kp clearance and survival upon infection in mice[30, 35].
However, less work has been done with regard to clinical investigations of these
cytokines/chemokines. Our study is the first to show the critical role of MCP-1 in neutrophil
recruitment and host defense during Kp infection. The mechanism of how MCP-1 controls
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the expression of G-CSF needs to be investigated in detail. Since cytokines have a pleiotropic
effect and several cytokines can have a common function, it is important to clearly dissect out
the signaling mechanisms during acute bacterial infections in order to utilize them as
therapies. However, when compared to the above mentioned cytokines G-CSF has potential
as a therapeutic agent in acute bacterial pneumonia with low side effects[29].

From a therapeutic stand point, it is important to select a cytokine that has a broad function in
the host defense. In this regard, MCP-1 has been shown to have multiple roles in the host
defense. MCP-1 is important for the recruitment of monocytes[15], neutrophils[11] and T
lymphocytes[36]. MCP-1 plays an important role in clearing apoptotic neutrophils[37] and
aids in the healing process by recruiting endothelial cells and promoting angiogenesis[38]. In
our study, MCP-1 regulates G-CSF and blood neutrophil numbers. Therefore, MCP-1 can
serve as a potential therapeutic agent to treat gram-negative bacterial pneumonia.
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